地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:13212737804
传真:18771997407
邮箱:sales@amyjet.com

艾美捷科技特约代理美国Fitzgerald公司产品。
美国Fitzgerald Industries International, Inc.(简称FII公司),专门供应研究和生产体外诊断试剂用原料,产品超过9000多种,主要产品有:
(1)免疫比浊法用特种蛋白抗体:ApoAI, ApoB, IgG, IgA, IgM, C3, C4, TRF, CRP, Lp(a), PA, Albumin, β2-Microglobulin, etc;
(2)化学发光免疫测定法(CLIA)、酶联免疫测定法(EIA)、放射免疫测定法(RIA)、荧光免疫法(FIA)测定用各类高纯单克隆、多克隆抗体,纯化抗原;
(3)癌症系列抗原和抗体,如CA50, CEA, CA, AFP, CA 125, CA15-3, CA19-9, CA72-4, etc;
(4)配对抗体和抗原,如性腺,甲状腺系列等。
Fitzgerald is a manufacturer and supplier of primary antibodies, secondary antibodies, recombinant and native proteins, ELISA kits, Serum and Plasma, and many other biological reagents. Our motto ‘Bringing Life to Science’ illustrates our personal approach to addressing the individual needs, interests and expertise of our customers. We believe that our outstanding customer service and excellent quality products at competitive prices are key to our success.
Fitzgerald的主要产品类型包括:
(1)PRIMARY ANTIBODIES
Monoclonal Antibodies (8795)
Conjugated Monoclonal Antibodies (1329)
Purified Polyclonal Antibodies (28322)
Polyclonal Antibodies (3331)
Conjugated Polyclonal Antibodies (1551)
Antibody Matched Pairs (516)
(2)SECONDARY ANTIBODIES
Unconjugated Secondary Antibodies (179)
Purified Secondary Antibodies (235)
Conjugated Secondary Antibodies (1209)
(3)PROTEINS
Recombinant Proteins (2179)
Conjugated Proteins (3031)
Hapten Conjugates (474)
Complements (22)
Blocking Peptides (10052)
Native Proteins (773)
(4)IMMUNOGLOBULINS
Purified Immunoglobulins (171)
Conjugated Immunoglobulins (114)
(5)BIOLOGICAL REAGENTS
Poly-HRP Products (53)
Enzymes (106)
Colloidal Gold & Silver Products (37)
Diluents (40)
Chemical Reference (123)
Surfactants (4)
Substrates (12)
IHC Reagents (54)
Mounting Media & Preservatives (5)
Controls & Calibrators (50)
Isotype Controls (61)
(6)RESEARCH KITS
(7)SERUM, PLASMA & BLOOD
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Fitzgerald"> Fitzgerald
英国Immuquest公司主要提供细胞周期、核相关、干细胞分化以及肿瘤标志物等相关抗体。
Founded in 2002, ImmuQuest offers a range of UNIQUE and NOVEL antibodies manufactured to the highest possible quality, at the forefront of scientific research.
Everything we do is developed with the needs of the researcher in mind. Wherever possible, our antibodies are tested across applications such as WB, ELISA, IHC (frozen and paraffin sections) and ICC/IF and published in our Datasheets. Many can be supplied in BESPOKE formats. The majority of Immuquest's antibodies are manufactured under our own strict control. That means that you will always know what you are ordering is of the highest possible quality.
ImmuQuest的主要产品包括:
Stem Cells
Transcription
Cardiovascular
Ageing
Cancer
Cell Biology
Cell Division
Cell Architecture
Tags & Cell Markers
Human Disease
Immunology
Inherited Diseases
Microbiology
Nuclear Signalling
Neuroscience
Signal Transduction
Sub Cellular markers
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="ImmuQuest"> ImmuQuest
瑞典MERCODIA公司是免疫诊断产品的开发机构和提供商。MERCODIA长期专注于心血管疾病,糖尿病和肥胖领域的ELISA临床诊断和科研方面的应用,并在全球范围内第一个研发并向市场推出胰岛素(INSULIN)ELISA检测试剂盒和OXLDL ELISA检测试剂盒。MERCODIA与瑞士ROCHE一道成为世界范围内的胰岛素检测的最权威的机构,是WHO推荐的金标准方法和产品,广泛被大学、医院、药厂所使用。
MERCODIA的产品理念是为客户提供诊断试剂的最高品质,提供优良的性能和可重复性的方便和易于使用的方法。在产品中使用单克隆抗体的产品,确保长期重复性。
Mercodia's Bioanalytical Service provides you with the experience, quality and reliability that are fundamental to a productive partnership. Our experienced team of managers, scientists, technicians and regulatory resources will support you in everything from study design to sample handling. We follow the most recent international guidelines and industry standard white papers for bioanalytical method development and validation.
Mercodia AB的主要产品包括:
Mercodia AKURIO Multiplex Islet Hormones
Mercodia Total GLP-1 NL-ELISA
Mercodia Glucagon Control – Low, Medium, High
Mercodia GLP-1 (9-36) amide Control - Low, Medium, High
Mercodia C-peptide ELISA
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

艾美捷科技代理Berry & Associates全系列修饰核苷酸等
美国 Berry & Associates 公司成立于1989年,提供近200种亚磷酰胺和核苷酸合成用固相交联单体,以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。
Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.







Berry & Associates的主要产品包括:
| 产品名称 | 产品编号 | 纯度 | 规格 |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2'-3'-Dideoxyguanosine | PR 3505 | ≥95% | 25 mg; 100 mg |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 2',3'-Dideoxyuridine | PY 7278 | ≥97% | 100 mg; 500 mg |
| 2',3'-Didehydro-2',3'-dideoxyuridine | PY 7279 | ≥97% | 25 mg; 100 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| 2-Amino-2'-deoxyadenosine | PR 3060 | ≥97% | 1 g; 5 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine | PR 3080 | ≥95% | 100 mg; 1 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-isobutyryl-2'-deoxyadenosine | PR 3130 | ≥95% | 100 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3670 | ≥95% | 100 mg; 1 g |
| 2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine | PR 3070 | ≥97% | 25 mg; 100 mg |
| 2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine | PR 3160 | ≥97% | 100 mg; 250 mg |
| 2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate | PR 3180 | ≥97% | 25 mg; 100 mg |
| 2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3680 | ≥97% | 100 mg; 1 g |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | PR 3006 | ≥95% | 25 mg; 100 mg |
| 8-Amino-2'-deoxyadenosine | PR 3115 | ≥97% | 10 mg; 100 mg |
| N6-(6-Aminohexyl)-2'-deoxyadenosine | PR 3120 | ≥90% | 100 mg; 1 g |
| 8-Azido-2'-deoxyadenosine | PR 3125 | ≥97% | 10 mg; 100 mg |
| N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | PR 3230 | ≥95% | 50 mg; 250 mg |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | PR 3260 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| 8-Benzyloxy-2'-deoxyadenosine | PR 3280 | ≥97% | 100 mg; 1 g |
| 8-Bromo-2'-deoxyadenosine | PR 3290 | ≥90% | 2 g; 10 g |
| 8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3320 | ≥95% | 100 mg; 1 g |
| 8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3340 | ≥97% | 0g (discontinued); |
| 2'-Deoxyadenosine Monohydrate | PR 3445 | ≥97% | 25 g; 100 g |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2-Fluoro-2'-deoxyadenosine | PR 3496 | ≥97% | 25 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| N6-Methyl-2'-deoxyadenosine | PR 3740 | ≥97% | 100 mg; 1 g |
| 4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine | PRA 10012 | ≥95% | 10 mg; 50 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| 7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine | PRA 10032 | ≥95% | 10 mg; 50 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 8-Allyloxy-2'-deoxyguanosine | PR 3010 | ≥90% | 0Discontinued; |
| 8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3015 | ≥90% | 1 g; 10 g |
| 8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3020 | ≥90% | 1 g; 10 g |
| 5'-Azido-5'-deoxyguanosine | PR 3225 | ≥90% | 5 mg; 10 mg |
| 8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3285 | ≥90% | 1 g; 10 g |
| 8-Bromo-2'-deoxyguanosine | PR 3300 | ≥90% | 1 g; 5 g |
| 8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine | PR 3310 | ≥97% | 500 mg; 1 g |
| 8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3330 | ≥90% | 250 mg; 1 g |
| 5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine | PR 3335 | ≥95% | 100 mg; 1 g |
| 2'-Deoxyguanosine monohydrate | PR 3452 | ≥97% | 10 g; 100 g |
| α-2'-Deoxyguanosine | PR 3455 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine | PR 3600 | ≥97% | 100 mg; 1 g |
| 3',5'-Di-O-acetyl-2'-deoxyguanosine | PR 3605 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine | PR 3630 | ≥97% | 100 mg; 1 g |
| N2-Ethyl-2'-deoxyguanosine | PR 3700 | ≥95% | 25 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| N2-Isobutyl-2'-deoxyguanosine | PR 3745 | ≥97% | 10 mg; 100 mg |
| N1-Methyl-2'-deoxyguanosine | PR 3748 | ≥97% | 25 mg; 1 g |
| N2-Methyl-2'-deoxyguanosine | PR 3750 | ≥97% | 25 mg; 100 mg |
| O6-Methyl-2'-deoxyguanosine | PR 3755 | ≥90% | 5 mg; 25 mg |
| 6-Thio-2'-deoxyguanosine | PR 3845 | ≥97% | 10 mg; 100 mg |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 2'-O-Methyladenosine | PR 3734 | ≥97% | 1 g; |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-thiouridine | PY 7575 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-(methylithio)uridine | PY 7577 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine | PR 3000 | ≥97% | 25 mg; 250 mg |
| 3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine | PR 3200 | ≥90% | 50 mg; 250 mg |
| 3'-Azido-2',3'-dideoxyadenosine | PR 3210 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-2',3'-dideoxyguanosine | PR 3220 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| N6-Benzoyl-3'-deoxyadenosine | PR 3240 | ≥97% | 100 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | PR 3250 | ≥97% | 100 mg; 1 g |
| 3'-Deoxyadenosine | PR 3430 | ≥97% | 10 mg; 100 mg |
| 3'-Deoxyguanosine | PR 3460 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine | PR 3590 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-3'-deoxyguanosine | PR 3690 | ≥97% | 20 mg; 100 mg |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine | PY 7230 | ≥97% | 100 mg; |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3040 | ≥97% | 1 g; |
| 2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3045 | ≥95% | 1 g; |
| 2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine | PR 3050 | ≥95% | 5 g; 25 g |
| 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3370 | ≥97% | 100 mg; 1 g |
| 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3380 | ≥90% | 100 mg; 1 g |
| 6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine | PR 3390 | ≥97% | 0 g; |
| 6-Chloro-9-(β-D-ribofuranosyl)purine | PR 3400 | ≥97% | 5 g; 10 g |
| Adenosine | PR 3005 | ≥97% | 100 g; 1 kg |
| 8-Methyladenosine | PR 3007 | ≥95% | 25 mg; 100 mg |
| Vidarabine | PR 3008 | ≥97% | 1 g; 5 g |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| N1-Methyladenosine hydroiodide | PR 3032 | ≥95% | 100 mg; 1 g |
| 2-Methyladenosine | PR 3035 | ≥97% | 10 mg; 25 mg |
| 5'-Chloro-5'-deoxyadenosine | PR 3360 | ≥97% | 100 mg; 1 g |
| N6-Methyladenosine | PR 3732 | ≥97% | 100 mg; 1 g |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10000 | ≥97% | 100 mg; 1 g |
| 2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10005 | ≥97% | 500 mg; 1 g |
| 4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine | PRA 10006 | ≥90% | 25 mg; 100 mg |
| 8-Azaadenosine | PRA 10007 | ≥97% | 20 mg; |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | PRA 10008 | ≥95% | 10 mg; 100 mg |
| 4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine | PRA 10009 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | PRA 10010 | ≥97% | 100 mg; 1 g |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; 1 g |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | PRA 10020 | ≥97% | 100 mg; 1 g |
| 3-Deaza-2'-deoxyadenosine | PRA 10025 | ≥97% | 25 mg; 100 mg |
| 7-Deaza-2'-deoxyadenosine | PRA 10030 | ≥97% | 100 mg; 1 g |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 7-Deaza-2'-deoxyguanosine | PRA 10040 | ≥97% | 100 mg; 1 g |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 7-Deaza-2'-deoxyxanthosine | PRA 10050 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine | PRA 10055 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10100 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10110 | ≥97% | 100 mg; 1 g |
| Sangivamycin | PRA 10140 | ≥97% | 10 mg; 25 mg |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; 100 mg |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| dNaM | FC 8110 | ≥97% | 25 mg; 100 mg |
| 9-Deaza-2'-deoxyguanosine | PRA 10120 | ≥97% | 10 mg; 100 mg |
| 9-Deazaguanosine | PRA 10130 | ≥97% | 10 mg; 100 mg |
| 2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine | PYA 11000 | ≥97% | 10 mg; 25 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| 2'-Deoxypseudoisocytidine | PYA 11005 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudouridine | PYA 11010 | Purity: ≥97% | 25 mg; |
| 5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine | PYA 11035 | Purity: ≥97% | 50 mg; 100 mg |
| 1,3-Dimethyl-2'-deoxypseudouridine | PYA 11040 | ≥97% | 10 mg; 100 mg |
| 1,3-Dimethylpseudouridine | PYA 11050 | ≥97% | 10 mg; 50 mg |
| N1-Methylpseudouridine | PYA 11052 | ≥95% | 10 mg; 50 mg |
| N3-Methylpseudouridine | PYA 11054 | ≥97% | 10 mg; 25 mg |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Pseudoisocytidine hydrochloride | PYA 11060 | ≥97% | 10 mg; 100 mg |
| Pseudothymidine | PYA 11070 | ≥97% | 10 mg; 100 mg |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; 50 mg |
| 3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine | PR 3350 | ≥97% | 10 mg; |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-Deoxy-8,5'-cycloadenosine | PR 3440 | ≥97% | 10 mg; 100 mg |
| 2',5'-Dideoxy-8,5'-cycloadenosine | PR 3500 | ≥97% | 10 mg; |
| 2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine | PR 3730 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-8,5'-cycloadenosine | PR 3800 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-2'-deoxy-8,5'-cycloadenosine | PR 3810 | ≥97% | 10 mg; |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | PY 7054 | ≥97% | 25 mg; 100 mg |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 5-Bromo-2'-deoxycytidine | PY 7115 | ≥97% | 1 g; 10 g |
| Cytidine | PY 7215 | ≥97% | 50 g; 500 g |
| 2'-Deoxycytidine | PY 7216 | ≥97% | 10 g; 50 g |
| 2'-Deoxycytidine Hydrochloride | PY 7217 | ≥97% | 5 g; 50 g |
| 5'-Azido-2',5'-dideoxycytidine | PY 7219 | ≥97% | 25 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| N4-Ethyl-2'-deoxycytidine | PY 7245 | ≥97% | 100 mg; 250 mg |
| 5-Methyl-2'-deoxyisocytidine | PY 7255 | ≥95% | 500 mg; 1 g |
| 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7270 | ≥97% | 20 mg; 50 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7380 | ≥97% | 50 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine | PY 7410 | ≥97% | 100 mg; |
| 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one | PY 7540 | ≥95% | 250 mg; 500 mg |
| Cytidin-5-yl-methanesulfonate sodium salt hydrate | PY 7586 | ≥95% | 50 mg; 100 mg |
| 5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine | PY 7587 | ≥97% | 10 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxycytidine | PY 7588 | ≥97% | 50 mg; 100 mg |
| 5-Formyl-2'-deoxycytidine | PY 7589 | ≥97% | 5 mg; 10 mg |
| 5-Carboethoxy-2'-deoxycytidine | PY 7592 | ≥95% | 25 mg; 100 mg |
| 2'-Deoxycytidine-5-carboxylic acid, sodium salt | PY 7593 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxymethylcytidine | PY 7596 | ≥97% | 50 mg; 100 mg |
| Cytidine-5-carboxylic acid, sodium salt | PY 7598 | ≥97% | 10 mg; 50 mg |
| 5-Formylcytidine | PY 7599 | ≥97% | 5 mg; 10 mg |
| 5-Iodo-2'-deoxycytidine | PY 7607 | ≥97% | 2 g; 10 g |
| 5-Iodocytidine | PY 7609 | ≥97% | 5 g; |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Methyl-2'-deoxycytidine Hydrochloride | PY 7635 | ≥97% | 0.25 g; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methylcytidine | PY 7637 | ≥97% | 1 g; 5 g |
| N4-Methylcytidine | PY 7638 | ≥97% | 25 mg; 100 mg |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 2-Thiocytidine | PY 7721 | ≥97% | 10 mg; 100 mg |
| 2-Thio-2'-deoxycytidine | PY 7723 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| 8-Hydroxyguanosine | PR 3795 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 5-Aza-2'-deoxycytidine | PY 7105 | ≥95% | 25 mg; 100 mg |
| 5,6-Dihydro-5-aza-2'-deoxycytidine | PY 7106 | ≥97% | 25 mg; 100 mg |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| Nap-dU | PY 7735 | ≥97% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 8-18O-Hydroxyguanosine | IOPR 3795 | ≥95% | 2 mg; 5 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| N2-Dimethylguanosine | PR 3702 | ≥97% | 10 mg; 100 mg |
| Guanosine | PR 3703 | ≥97% | 100 g; 500 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| O6-Methylguanosine | PR 3757 | ≥97% | 25 mg; 100 mg |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 8-Bromoguanosine | PR 3796 | ≥97% | 0 g; |
| 8-Benzyloxyguanosine | PR 3797 | ≥95% | 100 mg; 1 g |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 2'-Deoxy-4-desmethylwyosine | PR 3450 | ≥95% | 100 mg; 500 mg |
| 2'-Deoxyinosine | PR 3463 | ≥97% | 10 g; 100 g |
| 5'-Azido-2',5'-dideoxyinosine | PR 3464 | ≥97% | 5 mg; 25 mg |
| 3',5'-Di-O-acetyl-2'-deoxyinosine | PR 3480 | ≥97% | 1 g; |
| 3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine | PR 3490 | ≥90% | 1 g; |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| 5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | PR 3660 | ≥97% | 100 mg; 1 g |
| Inosine | PR 3725 | ≥97% | 100 g; 500 g |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| O6-Phenyl-2'-deoxyinosine | PR 3840 | ≥97% | 100 mg; 1 g |
| 2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3842 | ≥97% | 25 mg; |
| 5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3843 | ≥90% | 25 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | PR 3510 | ≥90% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3520 | ≥95% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3530 | ≥90% | 100 mg; 1 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| d5SICS | FC 8120 | ≥97% | 25 mg; 100 mg |
| AICA Riboside (AICAR) | MN 20001 | ≥97% | 0 g (DISCONTINUED); |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine | PR 3692 | ≥95% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| tC Nucleoside | PYA 11110 | ≥97% | 50 mg; 100 mg |
| tCnitro Nucleoside | PYA 11115 | ≥95% | 5 mg; 25 mg |
| 2'-Deoxynebularine | PR 3470 | Purity: ≥97% | 100 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole | PYA 11020 | ≥97% | 50 mg; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole | PYA 11030 | ≥95% | 100 mg; |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; |
| 5'-Amino-5'-deoxythymidine | PY 7030 | ≥97% | 25 mg; 50 mg |
| O2,5'-Anhydrothymidine | PY 7060 | ≥95% | 500 mg; 1 g |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 5'-Azido-5'-deoxythymidine | PY 7070 | ≥97% | 25 mg; 100 mg |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7120 | ≥97% | 1 g; |
| 3'-O-(t-Butyldimethylsilyl)thymidine | PY 7130 | ≥95% | 500 mg; 1 g |
| 5'-O-(t-Butyldimethylsilyl)thymidine | PY 7140 | ≥97% | 5 g; 10 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)thymidine | PY 7150 | ≥97% | 1 g; 5 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine | PY 7160 | ≥95% | 100 mg; 500 mg |
| S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine | PY 7200 | ≥95% | 10 mg; 100 mg |
| S4-(2-Cyanoethyl)-4-thiothymidine | PY 7210 | ≥95% | 10 mg; 100 mg |
| 5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7250 | ≥97% | 1 g; |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one | PY 7315 | ≥90% | 1 g; 10 g |
| 2',3'-Didehydro-3'-deoxythymidine | PY 7328 | ≥95% | 10 mg; 100 mg |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| 5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine | PY 7510 | ≥97% | 50 mg; 100 mg |
| 2-O-Ethylthymidine | PY 7561 | ≥97% | 500 mg; 1 g |
| 5'-Iodo-5'-deoxythymidine | PY 7610 | ≥97% | 250 mg; 1 g |
| 5'-O-Methylthymidine | PY 7680 | ≥95% | 50 mg; 100 mg |
| 2-Thiothymidine | PY 7725 | ≥95% | 20 mg; 100 mg |
| Thymidine | PY 7727 | ≥97% | 25 g; 250 g |
| 5'-O-(p-Toluenesulfonyl)thymidine | PY 7740 | ≥97% | 5 g; |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5'-Trifluoroacetamido-5'-deoxythymidine | PY 7750 | ≥97% | 50 mg; |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 6-Azathymidine | PYA 11058 | ≥95% | 25 mg; 100 mg |
| NPOM-Caged-dT CEP | BA 0317 | ≥95% | 100 µmol; 0.25 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 5-Ethynyl uridine CEP | BA 0353 | ≥90% | 100 µmol; 0.25 g |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 5-(Furan-2-yl)-2'-deoxyuridine | PY 7053 | ≥97% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one | PY 7055 | ≥97% | 20 mg; 100 mg |
| 5-Bromo-2'-deoxyuridine | PY 7117 | ≥97% | 10 g; 25 g |
| 5-Bromouridine | PY 7118 | ≥95% | 5 g; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carbomethoxyvinyl)uridine | PY 7172 | ≥97% | 25 mg; 250 mg |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)uridine | PY 7185 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine | PY 7212 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 2'-Deoxyuridine | PY 7275 | ≥97% | 25 g; 100 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine | PY 7280 | ≥95% | 100 mg; 500 mg |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7310 | ≥97% | 20 mg; 50 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine | PY 7450 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5-Methoxymethyl-2'-deoxyuridine | PY 7465 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-Ethynyl-2'-deoxyuridine | PY 7562 | ≥97% | 25 mg; 100 mg |
| 5-Ethynyl uridine | PY 7563 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-deoxyuridine | PY 7565 | ≥97% | 100 mg; 1 g |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7580 | ≥97% | 25 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7590 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Acetoxymethyl-2'-deoxyuridine | PY 7604 | ≥97% | 25 mg; 100 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 2'-Fluoro-5'-iodo deoxyuridine | PY 7612 | ≥95% | 100 mg; |
| 5-Iodo-2'-deoxyuridine | PY 7615 | ≥97% | 10 g; 25 g |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 5-Iodouridine | PY 7632 | ≥95% | 5 g; 25 g |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 3-Methyluridine | PY 7694 | ≥97% | 25 mg; 100 mg |
| 5-Methyluridine | PY 7695 | ≥97% | 200 mg; 1 g |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 5-(Propargyloxy)-2'-deoxyuridine | PY 7712 | ≥95% | 10 mg; 100 mg |
| Zebularine | PY 7715 | ≥97% | 10 mg; 25 mg |
| 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine | PY 7720 | ≥90% | 500 mg; 1 g |
| 2-Thiouridine | PY 7724 | ≥97% | 25 mg; 100 mg |
| 5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine | PY 7730 | ≥97% | 1 g; 5 g |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine | PY 7758 | ≥97% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| 5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine | PY 7775 | ≥97% | 100 mg; 1 g |
| Uridine | PY 7780 | ≥97% | 100 g; 500 g |
| 2'3'-O-Isopropylidene uridine | PY 7781 | ≥97% | 5 g; 25 g |
| 5-Hydroxymethyl uridine | PY 7782 | ≥97% | 50 mg; 100 mg |
| 5-Methoxyuridine | PY 7783 | ≥97% | 10 mg; 50 mg |
| 6-Aza-2'-deoxyuridine | PYA 11057 | ≥95% | 50 mg; 100 mg |
" data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸

eENZYME为科学界生产和销售高质量的生物试剂盒和生物分析试剂盒。与NIH密切合作以保证产品在生命科学研究的多个领域成功地使用。努力提供新颖价廉且有效的工具,使实验更容易成功。产品在科研、生物技术、制药和政府的研究实验室中得到广泛的应用,包括药物发现、癌症研究、传染病研究、微生物学和分子诊断。
eENZYME is a manufacturer and distributor of high quality biological reagents and bio-assay kits to the scientific community. We work closely with the NIH and CDC communities to guarantee the successful performance of our products for life science research in broad areas. We strive to provide innovative and cost effective tools to make your success easier.
Our products are used in academic, biotechnology, pharmaceutical and government research laboratories in many diverse applications that include drug discovery, cancer research, infectious disease research, microbiology and molecular diagnostics.
eEnzyme公司的主要产品包括:
Frontline Infectious Disease Products
Infectious Disease Antibodies & ELISA Kits
Recombinant Viral & Bacterial Proteins
Virus ORF cDNA Clone
Influenza Virus Research
HIV Research Tools
GPCR/PDE Cell-Based HTS Assays
Cell Assay & Molecule Detection Kits
PCR Tools
Mol. & Cell Biology Reagents
Animal-Free Human Proteins
Antibody & Protein Production
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="eEnzyme"> eEnzyme
KAMIYA公司旨在为生命科学和医疗机构提供高品质的创新的实验室研究和诊断工具。KAMIYA公司最早研发的产品是最前沿的用于信号转导研究的蛋白激酶抑制剂staurosporine(星形孢菌素)和K252a。1990年,KAMIYA成为美国第一家生产细胞凋亡研究的anti-Fas单克隆抗体的公司。如今,KAMIYA的产品线包括数千种人和动物临床前试验的生物标志物检测试试剂盒。此外,KAMIYA公司还为生命科学领域的研究着提供多种多样的酶抑制剂、单克隆抗体和多克隆抗体等产品,可用于研究细胞凋亡、耐药性、氧化、DNA损伤和修复、骨骼生物学、癌症、心脏病、炎症、肥胖症、糖尿病等研究。
KAMIYA公司K-ASSAY产品,用于胰岛素、血浆D-二聚体、凝血因子xiii、血浆FDP、血清/尿液 FPD、血清/尿液FDP-E、总IgE等指标的检测。KAMIYA现已发展成美国最大的脂质血清蛋白免疫分析试剂生厂商,为众多大型医院、医疗中心、临床实验室、临床参考实验室、科研机构、诊断试剂研发公司等机构提供优质的临床诊断试剂。
KAMIYA BIOMEDICAL COMPANY was founded by Kohji Kamiya in March of 1983 in Thousand Oaks, California and relocated to Seattle, Washington in 1996. Our company's purpose is supplying the life science and medical communities with innovative laboratory research and diagnostic tools of the highest quality. KAMIYA is an independent American company that serves worldwide markets.
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
< " data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Kamiya Biomedical"> Kamiya Biomedical
日本和光纯药工业株式会社“Wako”系列试剂涵盖了全面的生物化学、分析化学、有机化学、环境分析、食品·医药品分析、高纯度及认证标准品等多类,约50万种试剂。Wako尤以致力于某些当前特殊的高端领域,如:癌症病的研究及有效防治、农兽药残留物分析、中药研究、食品科学和水质分析等关乎人类健康的生命科学研究,并且独树一帜,经历大量成功实验应用案例从而奠定了其在试剂领域中强而有力的地位。
Wako的主要产品包括:
生物化学类
分析化学类
环境分析用试剂
合成用试剂
素材研究用试剂
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Wako"> Wako艾美捷科技授权代理Bioclone品牌全系列产品。
【快速入口】
丁香通:https://vicbio.biomart.cn/supply/c_cate-582257.htm
艾美捷科技商城:http://www.amyjet.com/Index/lists/catid/27/kid/74.html
【品牌介绍】

美国Bioclone Inc.公司成立已逾20年,其独特的“一步法”生物磁分离技术,已经在全球生物科学研究领域得到广泛应用,无论是大规模批量生产还是微量的生物样品处理,该技术都具有快速、简单、操作灵活的优势,目前是磁珠行业内先进技术的领跑者。我司代理Bioclone产品范围包括:负向磁珠、法医类试剂盒、蛋白纯化试剂、荧光磁珠、免疫磁珠、离子交换磁珠、反相磁珠及其他试剂盒等。
【一步法纯化平台】

【产品列表】
| 货号 | 中文名称 | 规格 | 价格(人民币) |
| FA101 | 1µm BcMag™ 氨基磁珠 150mg | 150mg | 4125 |
| FA102 | 1µm BcMag™ 氨基磁珠 300mg | 300mg | 7875 |
| FA103 | 5µm BcMag™ 氨基磁珠 150mg | 150mg | 4125 |
| FA104 | 5µm BcMag™ 氨基磁珠 300mg | 300mg | 7875 |
| FA105 | 1µm BcMag™ DADPA活化磁珠 150mg | 150mg | 4875 |
| FA106 | 2µm BcMag™ DADPA活化磁珠 300mg | 300mg | 9150 |
| FA107 | 5µm BcMag™ DADPA活化磁珠 150mg | 150mg | 4875 |
| FA108 | 5µm BcMag™ DADPA活化磁珠 300mg | 300mg | 9150 |
| FA113 | 1µm BcMag™ 长链氨基磁珠 150mg | 150mg | 4875 |
| FA114 | 1µm BcMag™ 长链氨基磁珠 300mg | 300mg | 9150 |
| FA115 | 5µm BcMag™ 长链氨基磁珠 150mg | 150mg | 4875 |
| FA116 | 5µm BcMag™ 长链氨基磁珠 300mg | 300mg | 9150 |
| FB101 | 1µm BcMag™ 羧基磁珠 150mg | 150mg | 4125 |
| FB102 | 1µm BcMag™ 羧基磁珠 300mg | 300mg | 7875 |
| FB103 | 5µm BcMag™ 羧基磁珠 150mg | 150mg | 4125 |
| FB104 | 5µm BcMag™ 羧基磁珠 300mg | 300mg | 7875 |
| FB105 | 1µm BcMag™ 长链羧基磁珠 150mg | 150mg | 4875 |
| FB106 | 1µm BcMag™ 长链羧基磁珠 300mg | 300mg | 9150 |
| FB107 | 5µm BcMag™ 长链羧基磁珠 150mg | 150mg | 4875 |
| FB108 | 5µm BcMag™ 长链羧基磁珠 300mg | 300mg | 9150 |
| FB113 | BcMag™ 羧基磁珠偶连试剂盒 | Kit | 4125 |
| FC101 | 1µm BcMag™ 环氧基活化磁珠 150mg | 150mg | 4125 |
| FC102 | 1µm BcMag™ 环氧基活化磁珠 300mg | 300mg | 7875 |
| FC103 | 5µm BcMag™ 环氧基活化磁珠 150mg | 150mg | 4125 |
| FC104 | 5µm BcMag™ 环氧基活化磁珠 300mg | 300mg | 7875 |
| FC105 | 1µm BcMag™ 长链环氧基活化磁珠 150mg | 150mg | 4875 |
| FC106 | 1µm BcMag™ 长链环氧基活化磁珠 300mg | 300mg | 9150 |
| FC107 | 5µm BcMag™ 长链环氧基活化磁珠 150mg | 150mg | 4875 |
| FC108 | 5µm BcMag™ 长链环氧基活化磁珠 300mg | 300mg | 9150 |
| FC109 | BcMag™ 环氧基活化磁珠偶连试剂盒 | Kit | 4125 |
| FD101 | 1µm BcMag™ 酰肼基磁珠 150mg | 150mg | 4125 |
| FD102 | 1µm BcMag™ 酰肼基磁珠 300mg | 300mg | 7875 |
| FD103 | 5µm BcMag™ 酰肼基磁珠 150mg | 150mg | 4125 |
| FD104 | 5µm BcMag™ 酰肼基磁珠 300mg | 300mg | 7875 |
| FD105 | BcMag™ 酰肼基磁珠偶连试剂盒 | Kit | 4125 |
| FD106 | BcMag™ 糖蛋白和抗体结合试剂盒,含1um酰肼磁珠 kit | kit | 5250 |
| FD107 | BcMag™ 糖蛋白和抗体结合试剂盒,含1um可洗脱式酰肼磁珠 kit | kit | 6750 |
| FE101 | 1µm BcMag™ 醛基磁珠 150mg | 150mg | 4125 |
| FE102 | 1µm BcMag™ 醛基磁珠 300mg | 300mg | 7875 |
| FE103 | 5µm BcMag™ 醛基磁珠 150mg | 150mg | 4125 |
| FE104 | 5µm BcMag™ 醛基磁珠 300mg | 300mg | 7875 |
| FE105 | 1µm BcMag™ 长链醛基磁珠 150mg | 150mg | 4875 |
| FE106 | 1µm BcMag™ 长链醛基磁珠 300mg | 300mg | 9150 |
| FE107 | 5µm BcMag™ 长链醛基磁珠 150mg | 150mg | 4875 |
| FE108 | 5µm BcMag™ 长链醛基磁珠 300mg | 300mg | 9150 |
| FE109 | BcMag™ 醛基磁珠偶连试剂盒 | Kit | 4125 |
| FF101 | 1µm BcMag™ 二氧化硅改良磁珠磁珠 150mg | 150mg | 3750 |
| FF102 | 1µm BcMag™ 二氧化硅改良磁珠磁珠 300mg | 300mg | 6750 |
| FF103 | 5µm BcMag™ 二氧化硅改良磁珠磁珠 150mg | 150mg | 3750 |
| FF104 | 5µm BcMag™ 二氧化硅改良磁珠磁珠 300mg | 300mg | 6750 |
| FF105 | 1µm BcMag™ IDA磁珠 5ml | 5ml | 4125 |
| FF106 | 1µm BcMag™ IDA磁珠 10ml | 10ml | 7875 |
| FF109 | 5µm BcMag™ IDA磁珠 150mg | 150mg | 4125 |
| FF110 | 5µm BcMag™ IDA磁珠 300mg | 300mg | 7875 |
| FG101 | 1µm BcMag™ 碘乙酰基活性磁珠 150mg | 150mg | 4125 |
| FG102 | 1µm BcMag™ 碘乙酰基活性磁珠 300mg | 300mg | 7875 |
| FG103 | 5µm BcMag™ 碘乙酰基活性磁珠 150mg | 150mg | 4125 |
| FG104 | 5µm BcMag™ 碘乙酰基活性磁珠 300mg | 300mg | 7875 |
| FG105 | 1µm BcMag™ 长链碘乙酰基活性磁珠 150mg | 150mg | 4875 |
| FG106 | 1µm BcMag™ 长链碘乙酰基活性磁珠 300mg | 300mg | 9150 |
| FG107 | 5µm BcMag™ 长链碘乙酰基活性磁珠 150mg | 150mg | 4875 |
| FG108 | 5µm BcMag™ 长链碘乙酰基活性磁珠 300mg | 300mg | 9150 |
| FG109 | BcMag™ 多肽偶联试剂盒,含1um碘乙酰基磁珠 Kit | Kit | 5250 |
| FG110 | BcMag™ 多肽偶联试剂盒,含1um可洗脱式碘乙酰基磁珠 Kit | Kit | 6750 |
| FG113 | BcMag™ 碘乙酰基磁珠偶连试剂盒 | Kit | 4125 |
| FH101 | 1µm BcMag™ DVS磁珠 150mg | 150mg | 4125 |
| FH102 | 1µm BcMag™ DVS磁珠 300mg | 300mg | 7875 |
| FH103 | 5µm BcMag™ DVS磁珠 150mg | 150mg | 4125 |
| FH104 | 5µm BcMag™ DVS磁珠 300mg | 300mg | 7875 |
| FI101 | 1µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4125 |
| FI102 | 1µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 7875 |
| FI103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4125 |
| FI104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 7875 |
| FI105 | 1µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4875 |
| FI106 | 1µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9150 |
| FI107 | 5µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4875 |
| FI108 | 5µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9150 |
| FI109 | BcMag™ NHS磁珠偶连试剂盒 | Kit | 4125 |
| FJ101 | 1µm BcMag™ 羟基磁珠 150mg | 150mg | 4125 |
| FJ102 | 1µm BcMag™ 羟基磁珠 300mg | 300mg | 7875 |
| FJ103 | 5µm BcMag™ 羟基磁珠 150mg | 150mg | 4125 |
| FJ104 | 5µm BcMag™ 羟基磁珠 300mg | 300mg | 7875 |
| FJ105 | 1µm BcMag™ 长链羟基磁珠 150mg | 150mg | 4875 |
| FJ106 | 1µm BcMag™ 长链羟基磁珠 300mg | 300mg | 9150 |
| FJ107 | 5µm BcMag™ 长链羟基磁珠 150mg | 150mg | 4875 |
| FJ108 | 5µm BcMag™ 长链羟基磁珠 300mg | 300mg | 9150 |
| FP101 | 1µm BcMag™ 巯基磁珠 150mg | 150mg | 4125 |
| FP102 | 1µm BcMag™ 巯基磁珠 300mg | 300mg | 7875 |
| FP103 | 5µm BcMag™ 巯基磁珠 150mg | 150mg | 4125 |
| FP104 | 5µm BcMag™ 巯基磁珠 300mg | 300mg | 7875 |
| FP105 | 1µm BcMag™ 长链巯基磁珠 150mg | 150mg | 4875 |
| FP106 | 1µm BcMag™ 长链巯基磁珠 300mg | 300mg | 9150 |
| FP107 | 5µm BcMag™ 长链巯基磁珠 150mg | 150mg | 4875 |
| FP108 | 5µm BcMag™ 长链巯基磁珠 300mg | 300mg | 9150 |
| FR101 | 1µm BcMag™ 对甲苯磺酰基磁珠 150mg | 150mg | 4125 |
| FR102 | 1µm BcMag™ 对甲苯磺酰基磁珠 300mg | 300mg | 7875 |
| FR103 | 5µm BcMag™ 对甲苯磺酰基磁珠 150mg | 150mg | 4125 |
| FR104 | 5µm BcMag™ 对甲苯磺酰基磁珠 300mg | 300mg | 7875 |
| FR105 | 1µm BcMag™ 长链对甲苯磺酰基磁珠 150mg | 150mg | 4875 |
| FR106 | 1µm BcMag™ 长链对甲苯磺酰基磁珠 300mg | 300mg | 9150 |
| FR107 | 5µm BcMag™ 长链对甲苯磺酰基磁珠 150mg | 150mg | 4875 |
| FR108 | 5µm BcMag™ 长链对甲苯磺酰基磁珠 300mg | 300mg | 9150 |
| FW101 | 1µm BcMag™ CDI磁珠 150mg | 150mg | 4125 |
| FW102 | 1µm BcMag™ CDI磁珠 300mg | 300mg | 7875 |
| FW103 | 5µm BcMag™ CDI磁珠 150mg | 150mg | 4125 |
| FW104 | 5µm BcMag™ CDI磁珠 300mg | 300mg | 7875 |
| FW111 | BcMag™ CDI磁珠偶连试剂盒 | Kit | 4125 |
| FX101 | 1µm BcMag™ 硫醇基磁珠 150mg | 150mg | 4125 |
| FX102 | 1µm BcMag™ 硫醇基磁珠 300mg | 300mg | 7875 |
| FX103 | 5µm BcMag™ 硫醇基磁珠 150mg | 150mg | 4125 |
| FX104 | 5µm BcMag™ 硫醇基磁珠 300mg | 300mg | 7875 |
| FX105 | 1µm BcMag™ 长链硫醇基磁珠 150mg | 150mg | 4875 |
| FX106 | 1µm BcMag™ 长链硫醇基磁珠 300mg | 300mg | 9150 |
| FX107 | 5µm BcMag™ 长链硫醇基磁珠 150mg | 150mg | 4875 |
| FX108 | 5µm BcMag™ 长链硫醇基磁珠 300mg | 300mg | 9150 |
| IL101 | 1µm BcMag™ 炔基磁珠 150mg | 150mg | 4125 |
| IL102 | 1µm BcMag™ 炔基磁珠 300mg | 300mg | 7875 |
| IL103 | 5µm BcMag™ 炔基磁珠 150mg | 150mg | 4125 |
| IL104 | 5µm BcMag™ 炔基磁珠 300mg | 300mg | 7875 |
| IM101 | 1µm BcMag™ 叠氮基活化磁珠 150mg | 150mg | 4125 |
| IM102 | 1µm BcMag™ 叠氮基活化磁珠 300mg | 300mg | 7875 |
| IM103 | 5µm BcMag™ 叠氮基活化磁珠 150mg | 150mg | 4125 |
| IM104 | 5µm BcMag™ 叠氮基活化磁珠 300mg | 300mg | 7875 |
| IA101 | 1µm BcMag™ 可洗脱式氨基磁珠 150mg | 150mg | 5625 |
| IA102 | 1µm BcMag™ 可洗脱式氨基磁珠 300mg | 300mg | 9750 |
| IA103 | 2.5µm BcMag™ 可洗脱式氨基磁珠 150mg | 150mg | 5625 |
| IA104 | 2.5µm BcMag™ 可洗脱式氨基磁珠 300mg | 300mg | 9750 |
| IB101 | 1µm BcMag™ 可洗脱式羧基磁珠 150mg | 150mg | 5625 |
| IB102 | 1µm BcMag™ 可洗脱式羧基磁珠 300mg | 300mg | 9750 |
| IB103 | 2.5µm BcMag™ 可洗脱式羧基磁珠 150mg | 150mg | 5625 |
| IB104 | 2.5µm BcMag™ 可洗脱式羧基磁珠 300mg | 300mg | 9750 |
| IC101 | 1µm BcMag™ 可洗脱式环氧基活化磁珠 150mg | 150mg | 5625 |
| IC102 | 1µm BcMag™ 可洗脱式环氧基活化磁珠 300mg | 300mg | 9750 |
| IC103 | 2.5µm BcMag™ 可洗脱式环氧基活化磁珠 150mg | 150mg | 5625 |
| IC104 | 2.5µm BcMag™ 可洗脱式环氧基活化磁珠 300mg | 300mg | 9750 |
| ID101 | 1µm BcMag™ 可洗脱式酰肼基磁珠 150mg | 150mg | 5625 |
| ID102 | 1µm BcMag™ 可洗脱式酰肼基磁珠 300mg | 300mg | 9750 |
| ID103 | 2.5µm BcMag™ 可洗脱式酰肼基磁珠 150mg | 150mg | 5625 |
| ID104 | 2.5µm BcMag™ 可洗脱式酰肼基磁珠 300mg | 300mg | 9750 |
| IE101 | 1µm BcMag™ 可洗脱式醛基磁珠 150mg | 150mg | 5625 |
| IE102 | 1µm BcMag™ 可洗脱式醛基磁珠 300mg | 300mg | 9750 |
| IE103 | 2.5µm BcMag™ 可洗脱式醛基磁珠 150mg | 150mg | 5625 |
| IE104 | 2.5µm BcMag™ 可洗脱式醛基磁珠 300mg | 300mg | 9750 |
| IG101 | 1µm BcMag™ 可洗脱式碘乙酰基活性磁珠 150mg | 150mg | 5625 |
| IG102 | 1µm BcMag™ 可洗脱式碘乙酰基活性磁珠 300mg | 300mg | 9750 |
| IG103 | 2.5µm BcMag™ 可洗脱式碘乙酰基活性磁珠 150mg | 150mg | 5625 |
| IG104 | 2.5µm BcMag™ 可洗脱式碘乙酰基活性磁珠 300mg | 300mg | 9750 |
| II101 | 1µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 5625 |
| II102 | 1µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9750 |
| II103 | 2.5µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 5625 |
| II104 | 2.5µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9750 |
| IJ101 | 1µm BcMag™ 可洗脱式叠氮基活化磁珠 150mg | 150mg | 5625 |
| IJ102 | 1µm BcMag™ 可洗脱式叠氮基活化磁珠 300mg | 300mg | 9750 |
| IJ103 | 2.5µm BcMag™ 可洗脱式叠氮基活化磁珠 150mg | 150mg | 5625 |
| IJ104 | 2.5µm BcMag™ 可洗脱式叠氮基活化磁珠 300mg | 300mg | 9750 |
| IK101 | 1µm BcMag™ 可洗脱式 炔基磁珠 150mg | 150mg | 5625 |
| IK102 | 1µm BcMag™ 可洗脱式 炔基磁珠 300mg | 300mg | 9750 |
| IK103 | 2.5µm BcMag™ 可洗脱式 炔基磁珠 150mg | 150mg | 5625 |
| IK104 | 2.5µm BcMag™ 可洗脱式 炔基磁珠 300mg | 300mg | 9750 |
| IR101 | 1µm BcMag™ 可洗脱式 对甲苯磺酰基磁珠 150mg | 150mg | 5625 |
| IR102 | 1µm BcMag™ 可洗脱式对甲苯磺酰基磁珠 300mg | 300mg | 9750 |
| IR103 | 2.5µm BcMag™ 可洗脱式对甲苯磺酰基磁珠 150mg | 150mg | 5625 |
| IR104 | 2.5µm BcMag™ 可洗脱式对甲苯磺酰基磁珠 300mg | 300mg | 9750 |
| AA101 | BcMag™ 一步法哺乳动物细胞DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AA102 | BcMag™ 一步法哺乳动物细胞DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AE101 | BcMag™ 一步法细菌DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AE102 | BcMag™ 一步法细菌DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AF101 | BcMag™ 一步法血液DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AF102 | BcMag™ 一步法血液DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AG101 | BcMag™ 一步法口腔细胞DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AG102 | BcMag™ 一步法口腔细胞DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AH101 | BcMag™ 一步法DNA/RNA纯化试剂盒 1ml | 1ml | 2250 |
| AH102 | BcMag™ 一步法DNA/RNA纯化试剂盒 5ml | 5ml | 6750 |
| AI101 | BcMag™ 一步法一代测序纯化试剂盒 1ml | 1ml | 2250 |
| AI102 | BcMag™ 一步法一代测序纯化试剂盒 5ml | 5ml | 6750 |
| AJ101 | BcMag™ One-Step FFPE & FNA DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AJ102 | BcMag™ One-Step FFPE & FNA DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AK101 | BcMag™ 一步法荧光标记物清除试剂盒 1ml | 1ml | 2250 |
| AK102 | BcMag™ 一步法荧光标记物清除试剂盒 5ml | 5ml | 10350 |
| AL101 | BcMag™ 一步法真菌和酵母DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AL102 | BcMag™ 一步法真菌和酵母DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AM101 | BcMag™ 一步法昆虫DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AM102 | BcMag™ 一步法昆虫DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AN101 | BcMag™ 一步法鼠尾DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AN102 | BcMag™ 一步法鼠尾DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AO101 | BcMag™ 一步法NGS纯化试剂盒 1ml | 1ml | 2250 |
| AO102 | BcMag™ 一步法NGS纯化试剂盒 5ml | 5ml | 10350 |
| AP101 | BcMag™ 一步法PCR纯化试剂盒 1ml | 1ml | 2250 |
| AP102 | BcMag™ 一步法PCR纯化试剂盒 5ml | 5ml | 10350 |
| AQ101 | BcMag™ 一步法植物DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AQ102 | BcMag™ 一步法植物DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AR101 | BcMag™ 一步法唾液病毒RNA-DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AR102 | BcMag™ 一步法唾液病毒RNA-DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AU101 | BcMag™ 一步法RNA清除试剂盒 1ml | 1ml | 2250 |
| AU102 | BcMag™ 一步法RNA清除试剂盒 3ml | 3ml | 5250 |
| AV101 | BcMag™ 一步法DNA/RNA清除试剂盒 1ml | 1ml | 2250 |
| AV102 | BcMag™ 一步法DNA/RNA清除试剂盒 3ml | 3ml | 5250 |
| AW101 | BcMag™ 一步法单链DNA清除试剂盒 1ml | 1ml | 2250 |
| AW102 | BcMag™ 一步法单链DNA清除试剂盒 3ml | 3ml | 5250 |
| AB101 | BcMag™ 骨骼DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AB102 | BcMag™ 骨骼DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AC101 | BcMag™ 游离DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AC102 | BcMag™ 游离DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AD101 | BcMag™ 发干DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AD102 | BcMag™ 发干DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AF101 | BcMag™ 一步法血液DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AF102 | BcMag™ 一步法血液DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AS101 | BcMag™ 一步法脱落细胞DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AS102 | BcMag™ 一步法脱落细胞DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AT101 | BcMag™ 精斑DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AT102 | BcMag™ 精斑DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AX101 | BcMag™ 一步法PCR抑制剂清除试剂盒 1ml | 1ml | 2250 |
| AX102 | BcMag™ 一步法PCR抑制剂清除试剂盒 5ml | 5ml | 10350 |
| AZ101 | BcMag™ 一步法指纹DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AZ102 | BcMag™ 一步法指纹DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AAA101 | BcMag™ 一步法头皮屑DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AAA102 | BcMag™ 一步法头皮屑DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| MG101 | BcMag™ GST-标签蛋白纯化试剂盒 Kit | Kit | 4425 |
| MG102 | BcMag™ GST-标签蛋白纯化试剂盒 5ml | 5ml | 5925 |
| MG103 | BcMag™ GST-标签蛋白纯化试剂盒 10ml | 10ml | 8250 |
| MHN101 | BcMag™ IDA-Ni His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHN102 | BcMag™ IDA-Ni His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| MHN103 | BcMag™ IDA-Ni His-标签蛋白纯化试剂盒 50ml | 50ml | 37500 |
| MHO101 | BcMag™ IDA-Co His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHO102 | BcMag™ IDA-Co His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| MHO103 | BcMag™ IDA-Co His-标签蛋白纯化试剂盒 50ml | 50ml | 37500 |
| MHP101 | BcMag™ 分泌型His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHP102 | BcMag™ 分泌型His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| MHQ101 | BcMag™ 低表达量His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHQ102 | BcMag™ 低表达量His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| HA101 | 2.5µm BcMag™ 链霉亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HA102 | 2.5µm BcMag™ 链霉亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HA103 | 5µm BcMag™ 链霉亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HA104 | 5µm BcMag™ 链霉亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HB101 | 2.5µm BcMag™ 链霉亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HB102 | 2.5µm BcMag™ 链霉亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HB103 | 5µm BcMag™ 链霉亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HB104 | 5µm BcMag™ 链霉亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HC101 | 2.5µm BcMag™ 链霉亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HC102 | 2.5µm BcMag™ 链霉亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HC103 | 5µm BcMag™ 链霉亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HC104 | 5µm BcMag™ 链霉亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HD101 | 2.5µm BcMag™ 单体亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HD102 | 2.5µm BcMag™ 单体亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HD103 | 5µm BcMag™ 单体亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HD104 | 5µm BcMag™ 单体亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HE101 | 2.5µm BcMag™ 单体亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HE102 | 2.5µm BcMag™ 单体亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HE103 | 5µm BcMag™ 单体亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HE104 | 5µm BcMag™ 单体亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HF101 | 2.5µm BcMag™ 单体亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HF102 | 2.5µm BcMag™ 单体亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HF103 | 5µm BcMag™ 单体亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HF104 | 5µm BcMag™ 单体亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HG101 | 2.5µm BcMag™ 蛋白A/G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HG102 | 2.5µm BcMag™ 蛋白A/G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HG103 | 5µm BcMag™ 蛋白A/G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HG104 | 5µm BcMag™ 蛋白A/G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HH101 | 2.5µm BcMag™ 蛋白A/G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HH102 | 2.5µm BcMag™ 蛋白A/G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HH103 | 5µm BcMag™ 蛋白A/G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HH104 | 5µm BcMag™ 蛋白A/G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HI101 | 2.5µm BcMag™ 蛋白A/G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HI102 | 2.5µm BcMag™ 蛋白A/G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HI103 | 5µm BcMag™ 蛋白A/G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HI104 | 5µm BcMag™ 蛋白A/G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HJ101 | 2.5µm BcMag™ 蛋白A铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HJ102 | 2.5µm BcMag™ 蛋白A铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HJ103 | 5µm BcMag™ 蛋白A铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HJ104 | 5µm BcMag™ 蛋白A铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HK101 | 2.5µm BcMag™ 蛋白A铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HK102 | 2.5µm BcMag™ 蛋白A铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HK103 | 5µm BcMag™ 蛋白A铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HK104 | 5µm BcMag™ 蛋白A铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HL101 | 2.5µm BcMag™ 蛋白A钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HL102 | 2.5µm BcMag™ 蛋白A钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HL103 | 5µm BcMag™ 蛋白A钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HL104 | 5µm BcMag™ 蛋白A钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HM101 | 2.5µm BcMag™ 蛋白G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HM102 | 2.5µm BcMag™ 蛋白G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HM103 | 5µm BcMag™ 蛋白G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HM104 | 5µm BcMag™ 蛋白G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HN101 | 2.5µm BcMag™ 蛋白G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HN102 | 2.5µm BcMag™ 蛋白G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HN103 | 5µm BcMag™ 蛋白G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HN104 | 5µm BcMag™ 蛋白G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HO101 | 2.5µm BcMag™ 蛋白G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HO102 | 2.5µm BcMag™ 蛋白G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HO103 | 5µm BcMag™ 蛋白G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HO104 | 5µm BcMag™ 蛋白G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HP101 | 2.5µm BcMag™ 蛋白L铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HP102 | 2.5µm BcMag™ 蛋白L铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HP103 | 5µm BcMag™ 蛋白L铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HP104 | 5µm BcMag™ 蛋白L铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HQ101 | 2.5µm BcMag™ 蛋白L铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HQ102 | 2.5µm BcMag™ 蛋白L铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HQ103 | 5µm BcMag™ 蛋白 L铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HQ104 | 5µm BcMag™ 蛋白L铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HR101 | 2.5µm BcMag™ 蛋白L钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HR102 | 2.5µm BcMag™ 蛋白L钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HR103 | 5µm BcMag™ 蛋白L钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HR104 | 5µm BcMag™ 蛋白L钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| GA101 | 2.5µm BcMag™ 醛基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GA102 | 2.5µm BcMag™ 醛基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GA103 | 5µm BcMag™ 醛基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GA104 | 5µm BcMag™ 醛基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GB101 | 2.5µm BcMag™ 醛基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GB102 | 2.5µm BcMag™ 醛基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GB103 | 5µm BcMag™ 醛基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GB104 | 5µm BcMag™ 醛基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GC101 | 2.5µm BcMag™ 醛基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GC102 | 2.5µm BcMag™ 醛基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GC103 | 5µm BcMag™ 醛基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GC104 | 5µm BcMag™ 醛基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GD101 | 2.5µm BcMag™ 氨基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GD102 | 2.5µm BcMag™ 氨基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GD103 | 5µm BcMag™ 氨基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GD104 | 5µm BcMag™ 氨基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GE101 | 2.5µm BcMag™ 氨基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GE102 | 2.5µm BcMag™ 氨基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GE103 | 5µm BcMag™ 氨基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GE104 | 5µm BcMag™ 氨基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GF101 | 2.5µm BcMag™ 氨基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GF102 | 2.5µm BcMag™ 氨基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GF103 | 5µm BcMag™ 氨基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GF104 | 5µm BcMag™ 氨基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GG101 | 2.5µm BcMag™ 羧基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GG102 | 2.5µm BcMag™ 羧基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GG103 | 5µm BcMag™ 羧基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GG104 | 5µm BcMag™ 羧基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GH101 | 2.5µm BcMag™ 羧基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GH102 | 2.5µm BcMag™ 羧基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GH103 | 5µm BcMag™ 羧基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GH104 | 5µm BcMag™ 羧基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GI101 | 2.5µm BcMag™ 羧基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GI102 | 2.5µm BcMag™ 羧基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GI103 | 5µm BcMag™ 羧基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GI104 | 5µm BcMag™ 羧基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GJ101 | 2.5µm BcMag™ 酰肼基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GJ102 | 2.5µm BcMag™ 酰肼基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GJ103 | 5µm BcMag™ 酰肼基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GJ104 | 5µm BcMag™ 酰肼基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GK101 | 2.5µm BcMag™ 酰肼基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GK102 | 2.5µm BcMag™ 酰肼基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GK103 | 5µm BcMag™ 酰肼基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GK104 | 5µm BcMag™ 酰肼基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GL101 | 2.5µm BcMag™ 酰肼基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GL102 | 2.5µm BcMag™ 酰肼基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GL103 | 5µm BcMag™ 酰肼基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GL104 | 5µm BcMag™ 酰肼基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GM101 | 2.5µm BcMag™ 碘乙酰基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GM102 | 2.5µm BcMag™ 碘乙酰基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GM103 | 5µm BcMag™ 碘乙酰基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GM104 | 5µm BcMag™ 碘乙酰基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GN101 | 2.5µm BcMag™ 碘乙酰基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GN102 | 2.5µm BcMag™ 碘乙酰基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GN103 | 5µm BcMag™ 碘乙酰基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GN104 | 5µm BcMag™ 碘乙酰基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GO101 | 2.5µm BcMag™ 碘乙酰基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GO102 | 2.5µm BcMag™ 碘乙酰基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GO103 | 5µm BcMag™ 碘乙酰基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GO104 | 5µm BcMag™ 碘乙酰基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GP101 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 15mg | 15mg | 3750 |
| GP102 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 30mg | 30mg | 6750 |
| GP103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 15mg | 15mg | 3750 |
| GP104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 30mg | 30mg | 6750 |
| GQ101 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 15mg | 15mg | 3750 |
| GQ102 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 30mg | 30mg | 6750 |
| GQ103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 15mg | 15mg | 3750 |
| GQ104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 30mg | 30mg | 6750 |
| GR101 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 15mg | 15mg | 3750 |
| GR102 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 30mg | 30mg | 6750 |
| GR103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 15mg | 15mg | 3750 |
| GR104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 30mg | 30mg | 6750 |
| MA101 | BcMag™ 蛋白 A/G 纯化试剂盒 Kit | Kit | 5250 |
| MA102 | BcMag™ 蛋白 A/G 磁珠 5ml | 5ml | 5850 |
| MA103 | BcMag™ 蛋白 A/G 磁珠 10ml | 10ml | 9750 |
| MAA101 | BcMag™ 蛋白 A磁珠纯化试剂盒 3ml beads kit | 3ml beads kit | 5250 |
| MAA102 | BcMag™ 蛋白A磁珠 5ml | 5ml | 5850 |
| MAA103 | BcMag™ 蛋白A磁珠 10ml | 10ml | 9750 |
| MAG101 | BcMag™ 蛋白 G磁珠纯化试剂盒 3ml beads kit | 3ml beads kit | 5250 |
| MAG102 | BcMag™ 蛋白G磁珠 5ml | 5ml | 5850 |
| MAG103 | BcMag™ 蛋白G磁珠 10ml | 10ml | 9750 |
| MAL101 | BcMag™ 蛋白 L磁珠纯化试剂盒 3ml beads kit | 3ml beads kit | 5250 |
| MAL102 | BcMag™ 蛋白L磁珠 5ml | 5ml | 5850 |
| MAL103 | BcMag™ 蛋白L磁珠 10ml | 10ml | 9750 |
| EA101 | BcMag™ 快速抗体纯化试剂盒 2ml | 2ml | 2250 |
| EA102 | BcMag™ 快速抗体纯化试剂盒 10ml | 10ml | 8250 |
| EB101 | BcMag™ 一步法抗体纯化试剂盒 2ml | 2ml | 2250 |
| EB102 | BcMag™ 一步法抗体纯化试剂盒 10ml | 10ml | 8250 |
| EC101 | BcMag™ 硼酸亲和磁珠磁珠 250mg | 250mg | 5175 |
| EC102 | BcMag™ 硼酸亲和磁珠磁珠 500mg | 500mg | 9750 |
| MMI101 | BcMag™ 单体亲和素磁珠 Kit | Kit | 7275 |
| MMI102 | BcMag™ 单体亲和素磁珠 5ml | 5ml | 8250 |
| MMI103 | BcMag™ 单体亲和素磁珠 10ml | 10ml | 14250 |
| MMI105 | BcMag™ 链酶亲和素磁珠 5ml | 5ml | 5250 |
| MMI106 | BcMag™ 链酶亲和素磁珠 10ml | 10ml | 9750 |
| MMI107 | BcMag™ 可洗脱式链酶亲和素磁珠 2ml | 2ml | 3750 |
| MMI108 | BcMag™ 可洗脱式链酶亲和素磁珠 5ml | 5ml | 8250 |
| MMI109 | BcMag™ 可洗脱式链酶亲和素磁珠 10ml | 10ml | 13500 |
| FM101 | 1µm BcMag™ DEAE 磁珠 250mg | 250mg | 5175 |
| FM102 | 1µm BcMag™ DEAE 磁珠 500mg | 500mg | 9750 |
| FM103 | 5µm BcMag™ DEAE 磁珠 250mg | 250mg | 5175 |
| FM104 | 5µm BcMag™ DEAE 磁珠 500mg | 500mg | 9750 |
| FM105 | 1µm BcMag™ PSA 磁珠 250mg | 250mg | 5175 |
| FM106 | 1µm BcMag™ PSA 磁珠 500mg | 500mg | 9750 |
| FM107 | 5µm BcMag™ PSA 磁珠 250mg | 250mg | 5175 |
| FM108 | 5µm BcMag™ PSA磁珠 500mg | 500mg | 9750 |
| FN101 | 1µm BcMag™ WCX 磁珠 250mg | 250mg | 5175 |
| FN102 | 1µm BcMag™ WCX 磁珠 500mg | 500mg | 9750 |
| FN103 | 5µm BcMag™ WCX 磁珠 250mg | 250mg | 5175 |
| FN104 | 5µm BcMag™ WCX 磁珠 500mg | 500mg | 9750 |
| FU101 | 1µm BcMag™ SAX 磁珠 250mg | 250mg | 5175 |
| FU102 | 1µm BcMag™ SAX 磁珠 500mg | 500mg | 9750 |
| FU103 | 5µm BcMag™ SAX 磁珠 250mg | 250mg | 5175 |
| FU104 | 5µm BcMag™ SAX 磁珠 500mg | 500mg | 9750 |
| FV101 | 1µm BcMag™ SCX 磁珠 250mg | 250mg | 5175 |
| FV102 | 1µm BcMag™ SCX 磁珠 500mg | 500mg | 9750 |
| FV103 | 5µm BcMag™ SCX 磁珠 250mg | 250mg | 5175 |
| FV104 | 5µm BcMag™ SCX 磁珠 500mg | 500mg | 9750 |
| DA101 | 1µm BcMag™ PEI 磁珠 250mg | 250mg | 5175 |
| DA102 | 1µm BcMag™ PEI 磁珠 500mg | 500mg | 9750 |
| DA103 | 5µm BcMag™ PEI磁珠 250mg | 250mg | 5175 |
| DA104 | 5µm BcMag™ PEI 磁珠 500mg | 500mg | 9750 |
| FO101 | 1µm BcMag™ 羟基磷灰石磁珠 250mg | 250mg | 5175 |
| FO102 | 1µm BcMag™ 羟基磷灰石磁珠 500mg | 500mg | 9750 |
| FK101 | 1µm BcMag™ C-8 磁珠 250mg | 250mg | 5175 |
| FK102 | 1µm BcMag™ C-8 磁珠 500mg | 500mg | 9750 |
| FK103 | 5µm BcMag™ C-8 磁珠 250mg | 250mg | 5175 |
| FK104 | 5µm BcMag™ C-8 磁珠 500mg | 500mg | 9750 |
| FL101 | 1µm BcMag™ C-18 磁珠 250mg | 250mg | 5175 |
| FL102 | 1µm BcMag™ C-18 磁珠 500mg | 500mg | 9750 |
| FL103 | 5µm BcMag™ C-18 磁珠 250mg | 250mg | 5175 |
| FL104 | 5µm BcMag™ C-18 磁珠 500mg | 500mg | 9750 |
| FS101 | 1µm BcMag™ C-4 磁珠 250mg | 250mg | 5175 |
| FS102 | 1µm BcMag™ C-4 磁珠 500mg | 500mg | 9750 |
| FS103 | 5µm BcMag™ C-4 磁珠 250mg | 250mg | 5175 |
| FS104 | 5µm BcMag™ C-4 磁珠 500mg | 500mg | 9750 |
| FS105 | 1µm BcMag™ 氰基丙基磁珠 250mg | 250mg | 5175 |
| FS106 | 1µm BcMag™ 氰基丙基磁珠 500mg | 500mg | 9750 |
| FS107 | 5µm BcMag™ 氰基丙基磁珠 250mg | 250mg | 5175 |
| FS108 | 5µm BcMag™ 氰基丙基磁珠 500mg | 500mg | 9750 |
| FT101 | 1µm BcMag™ 苯环基磁珠 250mg | 250mg | 5175 |
| FT102 | 1µm BcMag™ 苯环基磁珠 500mg | 500mg | 9750 |
| FT103 | 5µm BcMag™ 苯环基磁珠 250mg | 250mg | 5175 |
| FT104 | 5µm BcMag™ 苯环基磁珠 500mg | 500mg | 9750 |
| FT105 | 1µm BcMag™ 二苯基磁珠 250mg | 250mg | 5175 |
| FT106 | 1µm BcMag™ 二苯基磁珠 500mg | 500mg | 9750 |
| FT107 | 5µm BcMag™ 二苯基磁珠 250mg | 250mg | 5175 |
| FT108 | 5µm BcMag™ 二苯基磁珠 500mg | 500mg | 9750 |
| AY101 | BcMag™ 高纯度质粒提取试剂盒 5ml | 5ml | 4125 |
| AY102 | BcMag™ 高纯度质粒提取试剂盒 10ml | 10ml | 7875 |
| CA101 | BcMag™ 快速 Oligo-DNA偶联试剂盒 100mg Beads Kit | 100mg Beads Kit | 5400 |
| CA102 | BcMag™ 快速 Oligo-DNA偶联试剂盒 200mg Beads Kit | 200mg Beads Kit | 9750 |
| CA103 | BcMag™ RNA-DNA偶联试剂盒 100mg Beads Kit | 100mg Beads Kit | 5400 |
| CA104 | BcMag™ RNA-DNA偶联试剂盒 200mg Beads Kit | 200mg Beads Kit | 9750 |
| MMS101 | BcMag™ 快速mRNA提取纯化试剂盒 Kit | Kit | 4800 |
| MMS102 | BcMag™ Oligo-dT 磁珠 4ml | 4ml | 5700 |
| BA101 | BcMag™ 一步法脂质清除试剂盒 1ml | 1ml | 2250 |
| BA102 | BcMag™ 一步法脂质清除试剂盒 5ml | 5ml | 10350 |
| BB101 | BcMag™ 一步法脱蛋白清除试剂盒 1ml | 1ml | 2250 |
| BB102 | BcMag™ 一步法脱蛋白清除试剂盒 5ml | 5ml | 10350 |
| BC101 | BcMag™ 一步法SDS清除试剂盒 1ml | 1ml | 2250 |
| BC102 | BcMag™ 一步法SDS清除试剂盒 5ml | 5ml | 10350 |
| BD101 | BcMag™ 一步法去垢剂清除试剂盒 1ml | 1ml | 2250 |
| BD102 | BcMag™ 一步法去垢剂清除试剂盒 5ml | 5ml | 10350 |
| BE101 | BcMag™ 快速白蛋白清除试剂盒 25x preps Kit | 25x preps Kit | 3750 |
| BE102 | BcMag™ 快速白蛋白清除试剂盒 2.5ml beads, 100x preps | 2.5ml beads, 100x preps | 9750 |
| BF101 | BcMag™ 快速 HSA-IgG清除试剂盒 25x preps Kit | 25x preps Kit | 3750 |
| BF102 | BcMag™ 快速 HSA-IgG清除试剂盒 2.5ml beads, 100x preps | 2.5ml beads, 100x preps | 9750 |
| BG101 | BcMag™ 一步法染料清除试剂盒 1ml | 1ml | 2250 |
| BG102 | BcMag™ 一步法染料清除试剂盒 5ml | 5ml | 10350 |
| BH101 | BcMag™ 固定化TCEP二硫化物还原试剂盒 100mg | 100mg | 3750 |
| BH102 | BcMag™ 固定化TCEP二硫化物还原试剂盒 500mg | 500mg | 6750 |
| MKE101 | BcMag™ 快速内毒素清除试剂盒 Kit | Kit | 5250 |
| MKE102 | BcMag™ 快速内毒素清除试剂盒 5ml Beads | 5ml Beads | 7425 |
| MKE103 | BcMag™ 快速内毒素清除试剂盒 20ml of 10x regeneration buffers | 20ml of 10x regeneration buffers | 2535 |
| FQ101 | BcMag™ EDTA金属离子清除试剂盒 150mg | 150mg | 4125 |
| FQ102 | BcMag™ EDTA金属离子清除试剂盒 300mg | 300mg | 7875 |
| BI101 | BcMag™ EGTA金属离子清除试剂盒 150mg | 150mg | 4125 |
| BI102 | BcMag™ EGTA金属离子清除试剂盒 300mg | 300mg | 7875 |

Solulink公司致力于发展高性能的生物分子连接产品,他们不断的努力帮助你保持在生物科学研究的最前沿。可用于任何含有氨基的生物分子标记的ChromaLink™抗体标签试剂盒(ChromaLink™ Antibody Labeling Kit),和One-Shot(单标签)系列试剂盒的成功开发代表着他们始终如一地提供创新产品的承诺,以满足客户不断变化的需求。Solulink公司的产品包括:抗体标签、抗体-寡肽标签、生物素标签、磁珠及凝胶。
SoluLinK, Inc. provides linking reagents, conjugation kits, and conjugation services for life science research, diagnostics, and pharmaceutical markets. It offers biotin and digoxigenin labeling, magnetic beads and agarose, biotin and streptavidin, antibody labeling, antibody-oligo labeling, peptide linking and synthesis, and crosslinking products, as well as accessories. The company’s products are used in antibody, nanolink streptavidin magnetic beads, peptide conjugates, protein-peptide conjugates, solid phase peptide immobilization, streptavidin, protein conjugation kits, better biotin, and peplink linkable peptides applications. It offers its products through distributors and licensing partners in Australia, Austria, Belgium, Canada, China, the Czech Republic, Denmark, Finland, France, Germany, India, Ireland, Israel, Italy, Japan, South Korea, the Netherlands, Portugal, the Russian Federation, Singapore, Spain, Sweden, Switzerland, Taiwan, the United Kingdom, and the United States. SoluLinK, Inc. was incorporated in 2000 and is based in San Diego, California.
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Solulink"> Solulink
Neuromab是一家由NIH资助成立的单克隆抗体库。
The UC Davis/NIH NeuroMab Facility is a national monoclonal antibody-generating resource funded by the National Institutes of Health (NIH). The mission of the UC Davis/NIH NeuroMab Facility is to provide a unique neuroscience-based approach to generating mouse monoclonal antibodies optimized for use in mammalian brain (NeuroMabs). NeuroMabs are generated from mice immunized with synthetic and recombinant immunogens corresponding to components of the neuronal proteome as predicted from genomic and other large-scale cloning efforts. Comprehensive biochemical and immunohistochemical analyses of human, primate and non-primate mammalian brain are incorporated into the UC Davis/NIH NeuroMab Facility screening procedure. This yields a subset of mouse mAbs that are optimized for use in brain (i.e., NeuroMabs): for immunohistochemical- based imaging studies of protein localization in adult, developing and pathological brain samples, for biochemical analyses of subunit composition and post-translational modifications of native brain proteins, and for proteomic analyses of native brain protein networks.
Neuromab的主要产品包括:
Array Tomography
Model Organisms
Disease Targets
产品列表:
| 抗体名称 |
| Anti-5-formylcytidine, NeuroMab clone N358/68 |
| Anti-5-hydroxymethylcytidine, NeuroMab clone N297/59 |
| Anti-6xHis, NeuroMab clone N144/14 |
| Anti-ADAM11, NeuroMab clone N441/35 |
| Anti-ADAM22-cytoplasmic, NeuroMab clone N46/30 |
| Anti-ADAM22-extracellular, NeuroMab clone N57/2 |
| Anti-AGPS neo-epitope, NeuroMab clone N444/63 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/39 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/31 |
| Anti-Alg13, NeuroMab clone N442/28 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/80 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/51 |
| Anti-AMIGO-1, NeuroMab clone L86/33 |
| Anti-AMIGO-1, NeuroMab clone L86/36 |
| Anti-AMIGO-1, NeuroMab clone L86A/37 |
| Anti-Ankyrin-B, NeuroMab clone N105/13 |
| Anti-Ankyrin-B, NeuroMab clone N105/17 |
| Anti-Ankyrin-G, NeuroMab clone N106/20 |
| Anti-Ankyrin-G, NeuroMab clone N106/36 |
| Anti-Ankyrin-G, NeuroMab clone N106/65 |
| Anti-Ankyrin-G, NeuroMab clone N106/43 |
| Anti-Ankyrin-R, NeuroMab clone N388A/10 |
| Anti-Ankyrin-R/G, NeuroMab clone N388A/27 |
| Anti-ANO3/TMEM16C, NeuroMab clone N454/91 |
| Anti-ANO5/TMEM16E, NeuroMab clone N421A/85 |
| Anti-ANO6/TMEM16F, NeuroMab clone N429/19 |
| Anti-ARHGAP4, NeuroMab clone N290B/25 |
| Anti-Arl13b, NeuroMab clone N295B/66 |
| Anti-Arx, NeuroMab clone N411/51 |
| Anti-ASIC1, NeuroMab clone N271/44 |
| Anti-ATAT1, NeuroMab clone N347/42 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/8 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/3 |
| Anti-Ataxin-1 wild-type, NeuroMab clone N65/37 |
| Anti-ATF4, NeuroMab clone N360A/24 |
| Anti-BAF53a, NeuroMab clone N336B/83 |
| Anti-BAF53b, NeuroMab clone N332B/15 |
| Anti-Bassoon, NeuroMab clone L124/59 |
| Anti-BBS3/Arl6, NeuroMab clone N302/10 |
| Anti-BBS5, NeuroMab clone N304B/115 |
| Anti-BDNF, NeuroMab clone N450/53 |
| Anti-Beta1-spectrin, NeuroMab clone N385/21 |
| Anti-Beta4-spectrin, NeuroMab clone N393/2 |
| Anti-Beta4-spectrin, NeuroMab clone N393/76 |
| Anti-BKBeta2 potassium channel subunit, NeuroMab clone N53/32 |
| Anti-BKBeta3a potassium channel subunit, NeuroMab clone N40B/18 |
| Anti-BKBeta4 potassium channel, NeuroMab clone L18A/3 |
| Anti-Botch1/Chac1, NeuroMab clone N116/14 |
| Anti-Bral1, NeuroMab clone N364/10 |
| Anti-Bral1, NeuroMab clone N364/42 |
| Anti-Brevican, NeuroMab clone N294A/6 |
| Anti-Brevican, NeuroMab clone N294A/10 |
| Anti-CALB1/calbindin, NeuroMab clone L109/39 |
| Anti-CALB1/calbindin, NeuroMab clone L109/57 |
| Anti-CALB2/calretinin, NeuroMab clone L122/6 |
| Anti-CALB2/calretinin, NeuroMab clone L122/68 |
| Anti-CASK scaffolding protein, NeuroMab clone K56A/50 |
| Anti-Caspr/paranodin/neurexin IV, NeuroMab clone K65/35 |
| Anti-Caspr2/paranodin, NeuroMab clone K67/25 |
| Anti-Cav1.2 calcium channel, NeuroMab clone L57/46 |
| Anti-Cav1.2, NeuroMab clone N263/31 |
| Anti-Cav1.3 calcium channel, NeuroMab clone L48A/9 |
| Anti-Cav1.3 calcium channel, NeuroMab clone N38/8 |
| Anti-Cav3.1 Ca2+ channel, NeuroMab clone N178A/9 |
| Anti-Cav3.2 calcium channel, NeuroMab clone N55/10 |
| Anti-Cav1 calcium channel, NeuroMab clone N7/18 |
| Anti-Cav尾2 calcium channel subunit, NeuroMab clone N8b/1 |
| Anti-Cav3 calcium channel, NeuroMab clone N473/36 |
| Anti-Cav尾4 calcium channel, NeuroMab clone N10/7 |
| Anti-Cdkl5, NeuroMab clone EA7 |
| Anti-CDY1/2, NeuroMab clone N143/38 |
| Anti-CDY1/2/L1/L2, NeuroMab clone N143/36 |
| Anti-Celf4/Brunol4, NeuroMab clone N446/80 |
| Anti-FOS, NeuroMab clone N486/32 |
| Anti-FOS, NeuroMab clone N486/76 |
| Anti-Clcn3, NeuroMab clone N258/5 |
| Anti-Clcn4, NeuroMab clone N222/6 |
| Anti-Clcn5, NeuroMab clone N406/47 |
| Anti-CLN3, NeuroMab clone N380/87 |
| Anti-CLN6, NeuroMab clone N400/24 |
| Anti-CNGA1/3 cyclic nucleotide-gated channel, NeuroMab clone L36/12 |
| Anti-Collybistin, NeuroMab clone L120/12 |
| Anti-Collybistin, NeuroMab clone L120/30 |
| Anti-Contactin/F3 scaffold protein, NeuroMab clone K73/20 |
| Anti-Copper-transporting ATPase 1, NeuroMab clone L60/4 |
| Anti-Copper-transporting ATPase 2 (Copper pump 2, Wilsons disease-associated protein, NeuroMab clone L62/29 |
| Anti-Co-Rest/RCOR1 Transcriptional Co-Repressor, NeuroMab clone K72/8 |
| Anti-DEPDC5, NeuroMab clone N463/52 |
| Anti-Dicer, NeuroMab clone N167/7 |
| Anti-DLX1 transcription factor, NeuroMab clone L43/40 |
| Anti-DNAH1, NeuroMab clone N251/14 |
| Anti-DNAH7, NeuroMab clone N250/21 |
| Anti-DNAIC1, NeuroMab clone UNC 65.56.18.11 |
| Anti-DNMT3L, NeuroMab clone N117/9 |
| Anti-Doc2b, NeuroMab clone N150/21 |
| Anti-Dopamine D2 receptor, NeuroMab clone N186/29 |
| Anti-Dopamine D3 receptor, NeuroMab clone N331/19 |
| Anti-EAAC1, NeuroMab clone N420/24 |
| Anti-FGF11 (Fibroblast growth factor 11), NeuroMab clone N92/14 |
| Anti-FGF12/FHF1, NeuroMab clone N94/17 |
| Anti-FGF13 (Fibroblast growth factor 13), NeuroMab clone N91/27 |
| Anti-FGF13B/FHF2B, NeuroMab clone N225A/10 |
| Anti-FGF14/FHF4, NeuroMab clone N56/21 |
| Anti-Fig4/Sac3, NeuroMab clone N202/7 |
| Anti-Flrt3, NeuroMab clone N353/13 |
| Anti-Foxi2, NeuroMab clone N349/96 |
| Anti-Foxi3, NeuroMab clone N359/28 |
| Anti-Frataxin, NeuroMab clone N191/7 |
| Anti-GABA-A-R-Alpha1, NeuroMab clone N95/35 |
| Anti-GABA-A-R-Alpha2, NeuroMab clone N399/19 |
| Anti-GABA-A-R-Alpha4, NeuroMab clone N398A/34 |
| Anti-GABA-A-R-Alpha5, NeuroMab clone N415/24 |
| Anti-GABA-A-R-Alpha6, NeuroMab clone N229A/32 |
| Anti-GABA-A-R-Beta1, NeuroMab clone N96/55 |
| Anti-GABA-A-R-Beta2/3, NeuroMab clone 62-3G1 |
| Anti-GABA-A-R-Beta3, NeuroMab clone N87/25 |
| Anti-Delta GABA-A receptor, NeuroMab clone N151/3 |
| Anti-GABA-A-R-Epsilon, NeuroMab clone N413/67 |
| Anti-GABA-A-R-Gamma2L, NeuroMab clone N452/69 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/73 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/30 |
| Anti-GABA-A-R-Pi, NeuroMab clone N431/64 |
| Anti- GABA-A-R-Theta, NeuroMab clone L123/109 |
| Anti-GABABR1 GABA-B receptor, NeuroMab clone N93A/49 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/2 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/37 |
| Anti-GAD65/67, NeuroMab clone L127/12 |
| Anti-GAD67, NeuroMab clone L127/8 |
| Anti-Gamma-protocadherin-A3, NeuroMab clone N144/17 |
| Anti-Gamma-protocadherin-B2, NeuroMab clone N148/30 |
| Anti-Gamma-protocadherin-C3, NeuroMab clone N174B/27 |
| Anti-Gamma-protocadherin-C4, NeuroMab clone N193A/13 |
| Anti-Gephyrin, NeuroMab clone L106/83 |
| Anti-Gephyrin, NeuroMab clone L106/93 |
| Anti-Gephyrin, NeuroMab clone L106/4 |
| Anti-GFAP, NeuroMab clone N206A/8 |
| Anti-GFAP-R416WT, NeuroMab clone N206B/9 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/8 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/38 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/20 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/44 |
| Anti-GIT1 scaffold protein, NeuroMab clone N39B/8 |
| Anti-GIT2 scaffold protein, NeuroMab clone N83/48 |
| Anti-GluA1/GluR1 glutamate receptor, NeuroMab clone N355/1 |
| Anti-GluA2/GluR2 glutamate receptor, NeuroMab clone L21/32 |
| Anti-KA2 kainate receptor, NeuroMab clone N279B/27 |
| Anti-GluN1/NR1 glutamate receptor, NeuroMab clone N308/48 |
| Anti-NR2A glutamate receptor, NeuroMab clone N327A/38 |
| Anti-GluN2A/NR2A glutamate receptor, NeuroMab clone N327/95 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/20 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/36 |
| Anti-GluN2C/NR2C, NeuroMab clone N422/18 |
| Anti- GluN3A/NR3A, NeuroMab clone N416/40 |
| Anti-Glycine receptor Alpha3, NeuroMab clone N424/45 |
| Anti-Glycine receptor Alpha3L, NeuroMab clone N424/48 |
| Anti-GRK6A/B, NeuroMab clone N142/28 |
| Anti-Gs protein alpha subunit, NeuroMab clone N192/12 |
| Anti-GST (Glutathione S-transferase), NeuroMab clone N100/13 |
| Anti-Haspin/GSG2, NeuroMab clone N128A/2 |
| Anti-HCN1 cyclic nucleotide-gated channel, NeuroMab clone N70/28 |
| Anti-HCN2 cyclic nucleotide-gated channel, NeuroMab clone N71/37 |
| Anti-HCN3 cyclic nucleotide-gated channel, NeuroMab clone N141/28 |
| Anti-HCN4 cyclic nucleotide-gated channel, NeuroMab clone N114/10 |
| Anti-Histone H2A.Z/V, NeuroMab clone N310/21 |
| Anti-Histone H2A.Z acetyl-Lys4/7/11, NeuroMab clone N299/39 |
| Anti-Histone H3.3, NeuroMab clone N158/28 |
| Anti-Histone H3 acetyl-Lys56, NeuroMab clone N307/12 |
| Anti-Histone H3-dimethyl-Arg8, NeuroMab clone N293/50 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/19 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/48 |
| Anti-Histone H4-dimethyl-Arg3, NeuroMab clone N309A/21 |
| Anti-Homer1L, NeuroMab clone L113/27 |
| Anti-Homer1L, NeuroMab clone L113/13 |
| Anti-Homer1, NeuroMab clone L113/130 |
| Anti-ICK, NeuroMab clone N451/73 |
| Anti-Iduna/RNF146, NeuroMab clone N201/35 |
| Anti-INPP4b, NeuroMab clone N171/17 |
| Anti IP3 receptor type 1 NeuroMab clone L24/18 |
| Anti-IRSp53/BAIAP2, NeuroMab clone L117/1 |
| Anti-JIP-2/IB-2, NeuroMab clone N135/37 |
| Anti-JMJD2A, NeuroMab clone N154/32 |
| Anti-KCC2 transporter, NeuroMab clone N1/66 |
| Anti-KCC2 transporter, NeuroMab clone N1/12 |
| Anti-KChIP1 potassium channel, NeuroMab clone K55/7 |
| Anti-KChIP2 potassium channel subunit, NeuroMab clone K60/73 |
| Anti-KChIP3 potassium channel, NeuroMab clone K66/38 |
| Anti-KChIP4 K+ channel, NeuroMab clone N423/75 |
| Anti-KCNT1/Slo2.2/Slack K+ channel, NeuroMab clone N3/26 |
| Anti-KCNT2/Slo2.1/Slick sodium- and chloride-activated ATP sensitive potassium channel, NeuroMab clone N11/33 |
| Anti-KCNU1/Slo3 pH-sensitive maxi potassium channel, NeuroMab clone N2/16 |
| Anti-Keyhole limpet hemocyanin, NeuroMab clone N132A/12 |
| Anti-Kir2.1 potassium channel, NeuroMab clone N112B/14 |
| Anti-Kir2.2 potassium channel, NeuroMab clone N124B/38 |
| Anti-Kir2.3 potassium channel, NeuroMab clone N25/35 |
| Anti-Kir2.4 potassium channel, NeuroMab clone N465/11 |
| Anti-Kir3.3 potassium channel, NeuroMab clone N455/15 |
| Anti-Kir6.1 potassium channel, NeuroMab clone N366/60 |
| Anti-Kir6.2 potassium channel, NeuroMab clone N363/71 |
| Anti-Kirrel3 short and long, NeuroMab clone N321C/49 |
| Anti-Kirrel3 short isoform 3, NeuroMab clone N320/48 |
| Anti-Kv1.1 potassium channel subunit, NeuroMab clone K20/78 |
| Anti-Kv1.1 potassium channel (external), NeuroMab clone K36/15 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K14/16 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone L76/36 |
| Anti-Kv1.3 potassium channel, NeuroMab clone L23/27 |
| Anti-Kv1.4 potassium channel subunit, NeuroMab clone K13/31 |
| Anti-Kv1.4 potassium channel (extracellular), NeuroMab clone L71/5 |
| Anti-Kv1.5 potassium channel, NeuroMab clone K7/45 |
| Anti-Kv1.6 potassium channel subunit, NeuroMab clone K19/36 |
| Anti-Kv1.7 potassium channel, NeuroMab clone N471/27 |
| Anti-Kv11.3 potassium channel, NeuroMab clone N447/24 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L83/11 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone K89/34 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L80/21 |
| Anti-Kv2.1 potassium channel (external), NeuroMab clone K39/25 |
| Anti-Kv2.2 potassium channel, NeuroMab clone K37/89 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372C/51 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/60 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/1 |
| Anti-Kv3.1b potassium channel, NeuroMab clone N16b/8 |
| Anti-Kv3.2 potassium channel, NeuroMab clone N410/17 |
| Anti-Kv3.3 potassium channel, NeuroMab clone N375/67 |
| Anti-Kv3.4 potassium channel, NeuroMab clone N72/16 |
| Anti-Kv4.2 potassium channel subunit, NeuroMab clone L28/4 |
| Anti-Kv4.2 potassium channel (external), NeuroMab clone K57/1 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/41 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/30 |
| Anti-Kv6.1 potassium channel, NeuroMab clone N474/27 |
| Anti-Kv6.4 potassium channel, NeuroMab clone N458/10 |
| Anti-KCNQ1 potassium channel, NeuroMab clone N37A/10 |
| Anti-KCNQ2 potassium channel, NeuroMab clone N26A/23 |
| Anti-KCNQ4 potassium channel, NeuroMab clone N43/6 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/88 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/50 |
| Anti-Kv9.1 potassium channel, NeuroMab clone N461/19 |
| Anti-Kv9.2 potassium channel, NeuroMab clone N460/19 |
| Anti-Kvβ1.1 potassium channel subunit, NeuroMab clone K9/40 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K47/42 |
| Anti-Kv尾2 potassium channel, NeuroMab clone K17/70 |
| Anti-Laforin, NeuroMab clone N84/37 |
| Anti-LAR/PTPRF, NeuroMab clone N165/38 |
| Anti-Lgi1, NeuroMab clone N283/7 |
| Anti-Lhx6.1, NeuroMab clone N228A/16 |
| Anti-LRP4 (cytoplasmic), NeuroMab clone N164/6 |
| Anti-LRP4 (extracellular), NeuroMab clone N207/27 |
| Anti-LRRK1, NeuroMab clone N341/37 |
| Anti-LRRK1, NeuroMab clone N341/12 |
| Anti-LRRK2/Dardarin, NeuroMab clone N241A/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone N231B/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone 8G10 |
| Anti-LRRK2/Dardarin, NeuroMab clone N138/6 |
| Anti-LRRK2/Dardarin-pSer910, NeuroMab clone 1D8 |
| Anti-LRRTM2, NeuroMab clone N209C/35 |
| Anti-LRRTM4, NeuroMab clone N205B/22 |
| Anti-Mad3, NeuroMab clone N129A/6 |
| Anti-Mad3, NeuroMab clone N129/15 |
| Anti-Malin, NeuroMab clone N85/18 |
| Anti-MBP (Maltose-binding protein), NeuroMab clone N128A/4 |
| Anti-MAP3K12, NeuroMab clone N377/20 |
| Anti-MAP3K12, NeuroMab clone N377/83 |
| Anti-MECP2, NeuroMab clone N227/21 |
| Anti-MESD, NeuroMab clone N88/12 |
| Anti-MFF, NeuroMab clone N382/14 |
| Anti-MFF (exon 1), NeuroMab clone N382/69 |
| Anti-MGL, NeuroMab clone N90/20 |
| Anti-mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/3 |
| Anti- mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/33 |
| Anti-Miro2, NeuroMab clone N384/63 |
| Anti-MiRP4 potassium channel, NeuroMab clone N472/88 |
| Anti-Mitofusin-1 (Mfn1), NeuroMab clone N111/24 |
| Anti-Mitofusin-2 (Mfn2), NeuroMab clone N153/5 |
| Anti-MMACHC, NeuroMab clone N230/21 |
| Anti-MMP9 metalloproteinase, NeuroMab clone L51/82 |
| Anti-MOG, NeuroMab clone L94/54 |
| Anti-Mortalin/GRP75, NeuroMab clone N52A/42 |
| Anti-MPP8, NeuroMab clone N119/44 |
| Anti-NALCN, NeuroMab clone N185/7 |
| Anti-Nav1.1 sodium channel, NeuroMab clone K74/71 |
| Anti-Nav1.2 sodium channel, NeuroMab clone K69/3 |
| Anti-Nav1.4 sodium channel, NeuroMab clone N255/38 |
| Anti-Nav1.5 sodium channel, NeuroMab clone N397/19 |
| Anti-Nav1.6 sodium channel, NeuroMab clone K87A/10 |
| Anti-Nav1.7 sodium channel, NeuroMab clone N68/6 |
| Anti-Nav1.8 sodium channel, NeuroMab clone N134/12 |
| Anti-Navbeta1 Na+ channel, NeuroMab clone N405/74 |
| Anti-Navbeta2 Na+ channel, NeuroMab clone N395/68 |
| Anti-Navbeta3 Na+ channel, NeuroMab clone N396/29 |
| Anti-Navbeta4 sodium channel, NeuroMab clone N168/6 |
| Anti-NCKX4, NeuroMab clone N414/25 |
| Anti-Neuregulin-CRD (Cysteine-rich domain, Type III), NeuroMab clone N126B/31 |
| Anti-Neuregulin-HBD (Heparin-binding domain, Type I/II), NeuroMab clone N120A/9 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/1 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/26 |
| Anti-Neuroligin-1, NeuroMab clone N97A/31 |
| Anti-Neuroligin-2, NeuroMab clone L107/39 |
| Anti-Neuroligin-3, NeuroMab clone N110/29 |
| Anti-Neuroligin-4*, NeuroMab clone N98/47 |
| Anti-Neuroligin-4*, NeuroMab clone N98/7 |
| Anti-NGL-1 (Netrin-G1 ligand), NeuroMab clone N49A/21 |
| Anti-NGL-2 (Netrin-G2 ligand) NeuroMab clone N50/36 |
| Anti-NGL-3 (Netrin-G3 ligand), NeuroMab clone N51/6 |
| Anti-NKCC1, NeuroMab clone N161/20 |
| Anti-NOS1/nNOS, NeuroMab clone L121/25 |
| Anti-NOS1/nNOS, NeuroMab clone L121/42 |
| Anti-Notch1, NeuroMab clone N253/32 |
| Anti-Npas4, NeuroMab clone N408/62 |
| Anti-Npas4, NeuroMab clone N408/79 |
| Anti-Neuropeptide Y, NeuroMab clone L115/13 |
| Anti-NPY2R, NeuroMab clone L119/106 |
| Anti-NrCAM, NeuroMab clone N343/26 |
| Anti-NSD1, NeuroMab clone N312/10 |
| Anti-NSD3, NeuroMab clone N348/82 |
| Anti-OCRL/INPP5b, NeuroMab clone N166A/26 |
| Anti-Olig1, NeuroMab clone N149/25 |
| Anti-Pan-Ankyrin, NeuroMab clone N388A/60 |
| Anti-Pancortin, NeuroMab clone K96/7 |
| Anti-Pan-FHF-A, NeuroMab clone N235/22 |
| Anti-Pan-Gamma-protocadherin-A, NeuroMab clone N144/32 |
| Anti-Pan-Gamma-protocadherin, NeuroMab clone N159/5 |
| Anti-Pan-GRK, NeuroMab clone N145/20 |
| Anti-Pan-KChIP potassium channel, NeuroMab clone K55/82 |
| Anti-Pan-Kv potassium channel, NeuroMab clone K40/17 |
| Anti-Pan-Kvbeta potassium channel, NeuroMab clone K25/73 |
| Anti-Pan-MAGUK scaffold proteins, NeuroMab clone K28/86 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/40 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/78 |
| Anti-pan-Neurofascin, NeuroMab clone L11A/41 |
| Anti-Pan-Neurofascin (external), NeuroMab clone A12/18 |
| Anti-Pannexin-2, NeuroMab clone N121A/1 |
| Anti-Pannexin-2, NeuroMab clone N121A/31 |
| Anti-Pan-PTPR, NeuroMab clone N165/43 |
| Anti-Pan-QKI, NeuroMab clone N147/6 |
| Anti-Pan-SAPAP, NeuroMab clone N127/31 |
| Anti-pan-Shank (SH3 and multiple ankyrin repeat domains protein) scaffold protein, NeuroMab clone N23B/49 |
| Anti-Pan-Synapsin, NeuroMab clone L125/129 |
| Anti-Pan-Thyroid hormone receptor, NeuroMab clone N403/63 |
| Anti-PARIS/ZNF746, NeuroMab clone N196/16 |
| Anti-Parvalbumin, NeuroMab clone L114/3 |
| Anti-Parvalbumin, NeuroMab clone L114/81 |
| Anti-PEX6, NeuroMab clone N233/8 |
| Anti-PEX7, NeuroMab clone N232/9 |
| Anti-Phosphoserine-2-OEt, NeuroMab clone N257/25 |
| Anti-Phosphoserine-2-OH, NeuroMab clone N259/48 |
| Anti-Phosphoserine-2-OMe, NeuroMab clone N262/16 |
| Anti-PhyH/PAHX, NeuroMab clone N210/5 |
| Anti-PICK1 scaffold, NeuroMab clone L20/8 |
| Anti-PINK1, NeuroMab clone N4/15 |
| Anti-PINK1, NeuroMab clone N4/49 |
| Anti-PINK1, NeuroMab clone N4/19 |
| Anti-PINK1, NeuroMab clone N357/6 |
| Anti-Proser1, NeuroMab clone N456/39 |
| Anti-Prrt2, NeuroMab clone N485/22 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/30 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/28 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/43 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/74 |
| Anti-QKI-5-NLS, NeuroMab clone N195A/16 |
| Anti-QKI-6, NeuroMab clone N182/17 |
| Anti-QKI-7, NeuroMab clone N183/15 |
| Anti-QKI-7b, NeuroMab clone N194/11 |
| Anti-RBM17/SPF45, NeuroMab clone N219/5 |
| Anti-REEP, NeuroMab clone N326D/13 |
| Anti-REEP1, NeuroMab clone N345/51 |
| Anti-REEP1/2, NeuroMab clone N326D/29 |
| Anti-REEP2, NeuroMab clone N326D/2 |
| Anti-Rem2, NeuroMab clone N324/2 |
| Anti-RGS14, NeuroMab clone N133/21 |
| Anti-RGS14, NeuroMab clone N133/35 |
| Anti-Rufy3, NeuroMab clone N483/84 |
| Anti-Rufy3, NeuroMab clone N483/126 |
| Anti-Rufy3, NeuroMab clone N483/26 |
| Anti-S100A5, NeuroMab clone N176A/35 |
| Anti-SALM2 synaptic adhesion-like molecule, NeuroMab clone N52B/27 |
| Anti-SALM5/LRFN5, NeuroMab clone N140A/12 |
| Anti-SAP102 MAGUK scaffold protein, NeuroMab clone N19/2 |
| Anti-SAP97 scaffold protein, NeuroMab clone K64/15 |
| Anti-SAPAP1, NeuroMab clone N238/29 |
| Anti-SAPAP1, NeuroMab clone N238/30 |
| Anti-SAPAP1/2, NeuroMab clone N238/31 |
| Anti-SAPAP2, NeuroMab clone N459/84 |
| Anti-SAPAP3, NeuroMab clone L126/93 |
| Anti-SCG10/stathmin-2, NeuroMab clone L5/1 |
| Anti-SH3GL1, NeuroMab clone K51/1 |
| Anti-Shank1/ SPANK-1/Synamon/SSTRIP scaffold protein, NeuroMab clone N22/21 |
| Anti-Shank1 and Shank3, NeuroMab clone N367/51 |
| Anti-Shank2/ProSAP1/Spank-3/CortBP1 scaffold protein,NeuroMab clone N23B/6 |
| Anti-Shank3 scaffold protein, NeuroMab clone N69/46 |
| Anti-Shank3, NeuroMab clone N367/62 |
| Anti-SK2 potassium channel, NeuroMab clone K78/29 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/23 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/48 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/60 |
| Anti-Snapin (SNAP25 binding protein), NeuroMab clone L8/15 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/37 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/32 |
| Anti-SST/Somatostatin, NeuroMab clone L111/118 |
| Anti-S-tag, NeuroMab clone N56/9 |
| Anti-Stonin-2, NeuroMab clone N346/9 |
| Anti-SUR1, NeuroMab clone N289/16 |
| Anti-SUR1 and SUR2B, NeuroMab clone N323A/31 |
| Anti-SUR2A, NeuroMab clone N319A/14 |
| Anti-SUR2B, NeuroMab clone N323B/20 |
| Anti-SVOP, NeuroMab clone N356/9 |
| Anti-SVOP, NeuroMab clone N356/23 |
| Anti-Synapsin-III, NeuroMab clone L125/121 |
| Anti-Synaptotagmin-10, NeuroMab clone N269/73 |
| Anti-Synaptotagmin-12, NeuroMab clone N277/7 |
| Anti-Synaptotagmin-3, NeuroMab clone N278/19 |
| Anti-Synaptotagmin-5, NeuroMab clone N274/8 |
| Anti-Synaptotagmin-6, NeuroMab clone N270/47 |
| Anti-Synaptotagmin-7, NeuroMab clone N275/14 |
| Anti-Synaptotagmin-9, NeuroMab clone N276A/15 |
| Anti-SynCAM1 cell adhesion molecule, NeuroMab clone L45/30 |
| Anti-SynCAM4, NeuroMab clone N244/5 |
| Anti-SynDIG1/Tmem90b, NeuroMab clone L42/17 |
| Anti-SynDIG3/Tmem91, NeuroMab clone N160/21 |
| Anti-SynDIG4, NeuroMab clone L102/45 |
| Anti-Tafazzin, NeuroMab clone N173B/13 |
| Anti-TALK1 potassium channel, NeuroMab clone N466/14 |
| Anti-TARPGamma2/Stargazin, NeuroMab clone N245/1 |
| Anti-TARPGamma2/4/8, NeuroMab clone N245/36 |
| Anti-TASK1 potassium channel, NeuroMab clone N374/48 |
| Anti-Tauro-GM2, NeuroMab clone N175/9 |
| Anti-THAP1, NeuroMab clone N325B/65 |
| Anti-THIK-2 potassium channel, NeuroMab clone N468/37 |
| Anti-Thioredoxin, NeuroMab clone N245/44 |
| Anti-Thorase (Atad1), NeuroMab clone N125/10 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/13 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/46 |
| Anti- TRAAK potassium channel, NeuroMab clone N445/27 |
| Anti-TRAK1, NeuroMab clone N389/9 |
| Anti-TRAK2, NeuroMab clone N390/43 |
| Anti-TRESK potassium channel, NeuroMab clone N467/1 |
| Anti-TRIP8b (constant), NeuroMab clone N212/7 |
| Anti-TRIP8b (constant), NeuroMab clone N212/17 |
| Anti-TRIP8b (exon 1a/5 junction), NeuroMab clone N291C/22 |
| Anti-TRIP8b (exon 1b), NeuroMab clone N212A/34 |
| Anti-TRIP8b (exon 4), NeuroMab clone N212/3 |
| Anti-TrpC1 calcium channel, NeuroMab clone 1F1 |
| Anti-TrpC4 calcium channel, NeuroMab clone N77/15 |
| Anti-TrpC5 calcium channel, NeuroMab clone N67/15 |
| Anti-TrpC7 calcium channel, NeuroMab clone N64A/36 |
| Anti-TrpM4, NeuroMab clone L88/86 |
| Anti-TrpM6, NeuroMab clone N470/22 |
| Anti-TrpM7 ion channel and Ser/Thr kinase, NeuroMab clone N74/25 |
| Anti-TRPML3/Mucolipin-3, NeuroMab clone N268/19 |
| Anti-TrpV1, NeuroMab clone N221/17 |
| Anti-TrpV1, NeuroMab clone N221/12 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/4 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/39 |
| Anti-TWIK-2 potassium channel, NeuroMab clone N469/28 |
| Anti-Uncx, NeuroMab clone N155/9 |
| Anti-VAChT vesicular acetylcholine transporter, NeuroMab clone N6/38 |
| Anti-VAChT, NeuroMab clone N425/45 |
| Anti-VAPA, NeuroMab clone N479/12 |
| Anti-VAPA, NeuroMab clone N479/22 |
| Anti-VAPA/B, NeuroMab clone N479/107 |
| Anti-VDAC1, NeuroMab clone N152B/23 |
| Anti-Versican, NeuroMab clone N351/23 |
| Anti-Versican, NeuroMab clone N351/24 |
| Anti-VGAT, NeuroMab clone L118/80 |
| Anti-VGAT, NeuroMab clone L118/66 |
| Anti-VGlut1, NeuroMab clone N28/9 |
| Anti-VGlut2, NeuroMab clone N29/29 |
| Anti-VGlut3, NeuroMab clone N34/34 |
| Anti-VIP, NeuroMab clone L108/92 |
| Anti-VMAT1, NeuroMab clone N440/21 |
| Anti-VMAT1, NeuroMab clone N440/61 |
| Anti-Slc18a2/VMAT2, NeuroMab clone N449/73 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/21 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/63 |
| Anti-WAVE1/SCAR, NeuroMab clone K91/36 |
| Anti-WNK1, NeuroMab clone N391/68 |
| Anti-WRN, NeuroMab clone N428/12 |
| Zebrafish PSD Marker, NeuroMab clone N286/74 |
| Anti-Zinedin/Striatin-4, NeuroMab clone K88/64 |
| Anti-ZIP3, NeuroMab clone N476/9 |
| Anti-ZNF423, NeuroMab clone N328B/37 |
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771149750
传真:18771149750
邮箱:sales@amyjet.com
0.4312